cardio_surg_pubmed http://feed.informer.com/digests/9P30NM906K/feeder cardio_surg_pubmed Respective post owners and feed distributors Wed, 01 Aug 2018 19:37:36 +0000 Feed Informer http://feed.informer.com/ Clinical analysis of 11 cases of pregnancy with aortic dissection https://pubmed.ncbi.nlm.nih.gov/37072296/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:4e06376d-3821-f968-1717-e0bef49c5490 Wed, 19 Apr 2023 10:00:00 +0000 Objective: To investigate the treatment and maternal and fetal outcomes of pregnant women with aortic dissection (AD). Methods: The clinical data of 11 pregnant women with AD treated at the First Affiliated Hospital of Air Force Military Medical University from January 1st, 2011 to August 1st, 2022 were collected, and their clinical characteristics, treatment plans and maternal and fetal outcomes were analyzed retrospectively. Results: (1) Clinical characteristics: the age of onset of 11... <div><p style="color: #4aa564;">Zhonghua Fu Chan Ke Za Zhi. 2023 Apr 25;58(4):277-285. doi: 10.3760/cma.j.cn112141-20221130-00724.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"><b>Objective:</b> To investigate the treatment and maternal and fetal outcomes of pregnant women with aortic dissection (AD). <b>Methods:</b> The clinical data of 11 pregnant women with AD treated at the First Affiliated Hospital of Air Force Military Medical University from January 1st, 2011 to August 1st, 2022 were collected, and their clinical characteristics, treatment plans and maternal and fetal outcomes were analyzed retrospectively. <b>Results:</b> (1) Clinical characteristics: the age of onset of 11 pregnant women with AD was (30±5) years old, and the week of pregnancy of onset was (31.4±8.0) weeks. Clinical manifestations: the main symptoms were sudden onset of chest and back pain or low back pain. Type of AD: 8 cases of Stanford type A, and 3 cases of type B. The aortic width was (42±11) mm. Diagnostic methods: the diagnosis of AD was confirmed by transthoracic echocardiography (TTE), computed tomography angiography (CTA) or enhanced CT examination, among which 4 cases were confirmed by CTA examination, 4 cases by TTE examination, and 3 cases by enhanced CT examination. Laboratory results: white blood cell count was (15.4±8.7) ×10<sup>9</sup>/L, neutrophil count was (13.5±8.5) ×10<sup>9</sup>/L, the median D-dimer level was 2.7 mg/L (2.1-9.2 mg/L), and the median fibrin degradation products level was 12.0 mg/L (5.4-36.1 mg/L). (2) Treatments: all 11 patients were admitted to hospital in emergency. Before operation, the departments of cardiac surgery, obstetrics, pediatrics and anesthesiology cooperated to develop individualized treatment plan. Aortic surgery was performed in 11 pregnant women with AD. In 6 of them, pregnancy termination was performed at the same time as aortic surgery, and aortic surgery was performed after cesarean section. Four cases of pregnancy termination and aortic operation were performed by stages, including aortic operation after cesarean section in 2 cases, and cesarean section after aortic operation in 2 cases. One case (12<sup>+6</sup> weeks of gestation) had spontaneous abortion on the day after aortic surgery. The gestational age of the 11 patients on pregnancy termination was (32.9±7.4) weeks. Aorta surgical methods: 7 patients received under extracorporeal circulation ascending aorta replacement ± aortic valve replacement ± coronary artery transplantation (or coronary artery bypass transplantation)± left and right coronary Cabrol + total arch replacement (or aortic arch replacement)± stent implantation, 1 patient received under extracorporeal circulation aortic root replacement, and 3 patients underwent aortic endoluminal isolation. (3) Maternal and fetal outcomes: among the 11 pregnant women with AD, 9 (9/11) survived, 2 (2/11) died with lower limb ischemia before the onset of the disease. A total of 10 newborns were born in 9 pregnant women after delivery (1 of them was twins), and the 2 cases were spontaneous abortion after aortic surgery in the first trimester (12<sup>+6</sup> weeks) and fetal death after hysterotomy in the second trimester (26<sup>+3</sup> weeks), respectively. Among the 10 surviving neonates, 3 were full-term infants and 7 were premature infants. The birth weight of newborn was (2 651±784) g. Respiratory distress syndrome was found in 6 cases. The newborns were followed up for (5.6±3.6) years after birth, and the infants developed well during the follow-up period. <b>Conclusions:</b> Pregnancy complicated with AD is dangerous, and chest and back pain is the main clinical manifestation of this disease. With early identification and selection of appropriate diagnostic methods, multidisciplinary diagnosis and treatment, mother and children could obtain good outcomes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37072296/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37072296</a> | DOI:<a href=https://doi.org/10.3760/cma.j.cn112141-20221130-00724>10.3760/cma.j.cn112141-20221130-00724</a></p></div> The role of urinary Dickkopf-3 in the prediction of acute kidney injury: a systematic review meta-analysis https://pubmed.ncbi.nlm.nih.gov/37072601/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:6fbf3dd5-05b7-d923-fda6-baa2b5bf145b Tue, 18 Apr 2023 00:00:00 +0000 CONCLUSION: Urinary DKK3 may have limited predictive ability for acute kidney injury, especially for AKI associated with cardiac surgery. Therefore, urinary DKK3 may serve as a potential predictor for AKI. However, clinical studies with larger samples are still needed for validation. <div><p style="color: #4aa564;">Int Urol Nephrol. 2023 Apr 18. doi: 10.1007/s11255-023-03593-2. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: To systematically evaluate the diagnostic efficacy of urinary Dickkopf-Related Protein 3 (DKK-3) in acute kidney injury and to explore the clinical application value of urinary DKK-3.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHOD: English databases (PubMed, Embase, Cochrane, and WOS) and Chinese databases (VIP, WanFang data, and China National Knowledge Internet) were screened for relevant papers published before March 12, 2023. After literature screening and data extraction, quality assessment was performed according to the QUADAS-2 scoring system. Then, the combined diagnostic and predictive parameters were calculated using a bivariate mixed effect meta-analysis model. Deek's funnel plot asymmetry test assessed publication bias, and Fagan's nomogram plot was used to verify its clinical utility.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULT: A total of 5 studies involving 2787 patients were included in this meta-analysis, of which 4 focused on contrast-induced acute kidney injury (CI-AKI) and 1 focused on AKI associated with cardiac surgery. The analysis showed that urine Dickkopf-3 has high diagnostic accuracy for AKI, with a sensitivity of 0.55 (95% CI [0.41, 0.68]), specificity of 0.80 (95% CI [0.70, 0.87]), positive likelihood ratio (PLR) of 2.7 [1.8, 4.1], negative likelihood ratio (NLR) of 0.56 [0.42, 0.75], diagnostic odds ratio (DOR) of 5 [3, 9], and AUC of 0.74 [0.70-0.77]. We did not perform subgroup analyses for predictive value due to the small number of included studies.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Urinary DKK3 may have limited predictive ability for acute kidney injury, especially for AKI associated with cardiac surgery. Therefore, urinary DKK3 may serve as a potential predictor for AKI. However, clinical studies with larger samples are still needed for validation.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37072601/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37072601</a> | DOI:<a href=https://doi.org/10.1007/s11255-023-03593-2>10.1007/s11255-023-03593-2</a></p></div> Blood versus crystalloid cardioplegia during triple valve surgery: A single center experience https://pubmed.ncbi.nlm.nih.gov/37071759/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:aa1a3e5c-8536-2baa-aca3-7bbdb0e16134 Tue, 18 Apr 2023 00:00:00 +0000 CONCLUSIONS: Myocardial protection with HTK shows equivalent outcomes compared to BCP during TVS. Patients with reduced left ventricular function may benefit from BCP during TVS. <div><p style="color: #4aa564;">Perfusion. 2023 Apr 18:2676591231170707. doi: 10.1177/02676591231170707. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: The efficacy of different cardioplegia solutions on outcomes of complex cardiac operations such as triple valve surgery (TVS) is scarce. Here we compared the outcomes in TVS patients receiving either crystalloid (Bretschneider) or blood (Calafiore) cardioplegia.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Screening of our institutional database with prospectively entered data identified 471 consecutive patients (mean age 70.3 ± 9.2 years; 50.9% male), who underwent TVS (replacement or repair of aortic, mitral and tricuspid valve) between December 1994 and January 2013. In 277 patients, cardiac arrest was induced with HTK-Bretschneider solution (HTK, <i>n</i> = 277, 58.8%), whereas 194 received cold blood cardioplegia (BCP) according to Calafiore (<i>n</i> = 194, 41.2%). Comparisons of perioperative and follow up outcomes were made between cardioplegia groups.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Preoperative patient characteristics and comorbidities were equally balanced between groups. 30-days mortality was similar between groups (HTK: 16.2%; BCP: 18.2%; <i>p</i> = 0.619). Incidence of the cumulative endpoint (30days mortality, myocardial infarction (MI), arrhythmia, low cardiac output syndrome or need for permanent pacemaker implantation) was also comparable (HTK: 47.6%; BCP: 54.8%, <i>p</i> = 0.149). In patients with reduced left ventricular ejection fraction (LVEF &lt;40%), 30days mortality was higher in the HTK group (HTK 18/71 22.5%; BCP 5/50 10%; <i>p</i> = 0.037). Five-year survival was similar between groups (52 ± 6% for HTK and 55 ± 5% for BCP patients). In-Hospital mortality was best predicted by length of surgery and reperfusion ratio. Decreased age, shorter bypass time, preserved LVEF and concomitant surgical procedures have been found to be protective from long-term mortality.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Myocardial protection with HTK shows equivalent outcomes compared to BCP during TVS. Patients with reduced left ventricular function may benefit from BCP during TVS.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37071759/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37071759</a> | DOI:<a href=https://doi.org/10.1177/02676591231170707>10.1177/02676591231170707</a></p></div> Invited Commentary: Where to Turn When the Bleeding Won't Stop: Choosing Factor Concentrates for Significant Bleeding After Pediatric Cardiac Surgery https://pubmed.ncbi.nlm.nih.gov/37071569/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:d469d607-3114-6dd5-e059-d51c2e4134d5 Tue, 18 Apr 2023 00:00:00 +0000 No abstract <div><p style="color: #4aa564;">World J Pediatr Congenit Heart Surg. 2023 May;14(3):289-290. doi: 10.1177/21501351231164067.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37071569/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37071569</a> | DOI:<a href=https://doi.org/10.1177/21501351231164067>10.1177/21501351231164067</a></p></div> Emerging Modalities for Temporary Mechanical Circulatory Support in Cardiogenic Shock https://pubmed.ncbi.nlm.nih.gov/37071110/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:dbd70bad-13e8-8ebf-f8ff-2b34330caf18 Tue, 18 Apr 2023 00:00:00 +0000 Cardiogenic shock (CS) is a life-threatening medical condition that requires prompt recognition and treatment. The use of standardized CS criteria, such as the Society for Cardiovascular Angiography and Interventions criteria, can categorize patients and guide therapeutic strategies. Temporary mechanical circulatory support (MCS) devices have become valuable tools in the treatment of CS, as they can provide cardiovascular support as a bridge to recovery, cardiac surgery, or advanced therapies... <div><p style="color: #4aa564;">Cardiol Rev. 2023 Apr 6. doi: 10.1097/CRD.0000000000000549. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cardiogenic shock (CS) is a life-threatening medical condition that requires prompt recognition and treatment. The use of standardized CS criteria, such as the Society for Cardiovascular Angiography and Interventions criteria, can categorize patients and guide therapeutic strategies. Temporary mechanical circulatory support (MCS) devices have become valuable tools in the treatment of CS, as they can provide cardiovascular support as a bridge to recovery, cardiac surgery, or advanced therapies such as cardiac transplant or durable ventricular assist devices. The use of MCS should be tailored to each individual patient, focused on a stepwise escalation of circulatory support to support both end-organ perfusion and myocardial recovery. As newer MCS devices reduce myocardial oxygen demand without increasing ischemia, the possibility of recovery is optimized. In this review, we discuss the different modalities of MCS focusing on the mechanism of support and the advantages and disadvantages of each device.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37071110/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37071110</a> | DOI:<a href=https://doi.org/10.1097/CRD.0000000000000549>10.1097/CRD.0000000000000549</a></p></div> Machine learning to predict myocardial injury and death after non-cardiac surgery https://pubmed.ncbi.nlm.nih.gov/37070957/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:fa22ae71-43f8-388b-5fa1-914fdc7d1545 Tue, 18 Apr 2023 00:00:00 +0000 Myocardial injury due to ischaemia within 30 days of non-cardiac surgery is prognostically relevant. We aimed to determine the discrimination, calibration, accuracy, sensitivity and specificity of single-layer and multiple-layer neural networks for myocardial injury and death within 30 postoperative days. We analysed data from 24,589 participants in the Vascular Events in Non-cardiac Surgery Patients Cohort Evaluation study. Validation was performed on a randomly selected subset of the study... <div><p style="color: #4aa564;">Anaesthesia. 2023 Apr 18. doi: 10.1111/anae.16024. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Myocardial injury due to ischaemia within 30 days of non-cardiac surgery is prognostically relevant. We aimed to determine the discrimination, calibration, accuracy, sensitivity and specificity of single-layer and multiple-layer neural networks for myocardial injury and death within 30 postoperative days. We analysed data from 24,589 participants in the Vascular Events in Non-cardiac Surgery Patients Cohort Evaluation study. Validation was performed on a randomly selected subset of the study population. Discrimination for myocardial injury by single-layer vs. multiple-layer models generated areas (95%CI) under the receiver operating characteristic curve of: 0.70 (0.69-0.72) vs. 0.71 (0.70-0.73) with variables available before surgical referral, p &lt; 0.001; 0.73 (0.72-0.75) vs. 0.75 (0.74-0.76) with additional variables available on admission, but before surgery, p &lt; 0.001; and 0.76 (0.75-0.77) vs. 0.77 (0.76-0.78) with the addition of subsequent variables, p &lt; 0.001. Discrimination for death by single-layer vs. multiple-layer models generated areas (95%CI) under the receiver operating characteristic curve of: 0.71 (0.66-0.76) vs. 0.74 (0.71-0.77) with variables available before surgical referral, p = 0.04; 0.78 (0.73-0.82) vs. 0.83 (0.79-0.86) with additional variables available on admission but before surgery, p = 0.01; and 0.87 (0.83-0.89) vs. 0.87 (0.85-0.90) with the addition of subsequent variables, p = 0.52. The accuracy of the multiple-layer model for myocardial injury and death with all variables was 70% and 89%, respectively.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37070957/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37070957</a> | DOI:<a href=https://doi.org/10.1111/anae.16024>10.1111/anae.16024</a></p></div> Evaluation of Latex Immunoturbidimetric Assay Thresholds and HIT in Cardiothoracic Surgery https://pubmed.ncbi.nlm.nih.gov/37069794/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:0fee2a47-750f-4827-abeb-42cbee8dcfd8 Tue, 18 Apr 2023 00:00:00 +0000 CONCLUSION: This study suggests that the diagnostic accuracy of the LIA can be optimized by increasing the LIA positivity threshold. Proposing a higher LIA cutoff, may mitigate unwarranted anticoagulation and bleeding outcomes. <div><p style="color: #4aa564;">Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231166370. doi: 10.1177/10760296231166370.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Heparin-induced thrombocytopenia (HIT) is a common differential diagnosis in cardiothoracic surgery. The latex immunoturbidimetric assay (LIA) is an enhanced immunoassay that has recently been introduced for the detection of total HIT immunoglobulin and retains a higher specificity of 95% compared to the enzyme-linked immunosorbent assay.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: To investigate if a semiquantitative relationship exists between increasing LIA levels beyond the current positivity threshold and its correlation to positive serotonin release assay results in cardiothoracic surgery.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: This was a multicenter, observational cohort of cardiothoracic surgery patients initiated on anticoagulation with heparin-based products. To conduct sensitivity and specificity analysis of LIA values, HIT positive was defined as a LIA value ≥1 unit/mL and HIT negative was defined as a LIA level &lt;1 unit/mL. A receiver operating characteristic (ROC) analysis was utilized to evaluate the predictive performance of the LIA.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: At manufactures' cutoffs of ≥1.0 unit/mL, LIA sensitivity and specificity was 93.8% and 22%, respectively, yielding a false positive rate of 78%. At a higher cutoff of 4.5 units/mL, LIA sensitivity and specificity was 75% and 71%, respectively, yielding a false positive rate of 29% and an area under the ROC curve of 0.75 (<i>P</i> = .01; 95% confidence interval: 0.621-0.889). Bivalirudin was initiated in 84.6% of false positive LIA results.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: This study suggests that the diagnostic accuracy of the LIA can be optimized by increasing the LIA positivity threshold. Proposing a higher LIA cutoff, may mitigate unwarranted anticoagulation and bleeding outcomes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37069794/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37069794</a> | DOI:<a href=https://doi.org/10.1177/10760296231166370>10.1177/10760296231166370</a></p></div> Retrospective study assessing outcomes in cardiac surgery after implementation of Quantra https://pubmed.ncbi.nlm.nih.gov/37069685/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:0618181b-b688-da2a-74a6-15f1a429f66b Tue, 18 Apr 2023 00:00:00 +0000 CONCLUSIONS: Use of the Quantra QPlus System has the potential to improve patient blood management and decrease costs. STUDY REGISTERED AT CLINICALTRIALS.GOV: NCT05501730. <div><p style="color: #4aa564;">J Cardiothorac Surg. 2023 Apr 17;18(1):149. doi: 10.1186/s13019-023-02245-x.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: The Quantra QPlus System is a cartridge-based device with a unique ultrasound technology that can measure the viscoelastic properties of whole blood during coagulation. These viscoelastic properties correlate directly with hemostatic function. The primary objective of this study was to assess blood product utilization in cardiac surgery patients before and after the implementation of the Quantra QPlus System.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Yavapai Regional Medical Center implemented the Quantra QPlus System to aid in their efforts to reduce the transfusion of allogenic blood products and improve outcomes in patients undergoing cardiac surgery. A total of 64 patients were enrolled prior to the utilization of the Quantra (pre-Quantra cohort), and 64 patients were enrolled after (post-Quantra cohort). The pre-Quantra cohort had been managed via standard laboratory assays along with physician discretion for transfusion decisions. The utilization of blood products and frequency of transfusions were compared and analyzed between the two cohorts. (using the Student's t-test) RESULTS: The implementation of the Quantra resulted in a change in the pattern of blood product utilization leading to a demonstrated decrease in the amount of blood products transfused and the associated costs. The amount of FFP transfused was significantly decreased by 97% (P = 0.0004), whereas cryoprecipitate decreased by 67% (P = 0.3134), platelets decreased by 26% (P = 0.4879), and packed red blood cells decreased by 10% (P = 0.8027) however these trends did not reach statistical significance. The acquisition cost of blood products decreased by 41% for total savings of roughly $40,682.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Use of the Quantra QPlus System has the potential to improve patient blood management and decrease costs. STUDY REGISTERED AT CLINICALTRIALS.GOV: NCT05501730.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37069685/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37069685</a> | DOI:<a href=https://doi.org/10.1186/s13019-023-02245-x>10.1186/s13019-023-02245-x</a></p></div> Assessment method of cognitive load and stress inducer factors of surgeons and anesthetists in the operating room https://pubmed.ncbi.nlm.nih.gov/37068974/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:757b8563-331d-6d95-cb22-e8b776060e25 Mon, 17 Apr 2023 00:00:00 +0000 CONCLUSION: The articles reviewed use only some of the available tools for assessment of stress and cognitive load. The main objective is to improve the quality of care and the quality of life of caregivers. It would be interesting to develop other methods to identify and better characterize the risk factors that increase stress and cognitive load. <div><p style="color: #4aa564;">J Fr Ophtalmol. 2023 Apr 15:S0181-5512(23)00142-0. doi: 10.1016/j.jfo.2022.11.021. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">INTRODUCTION: For many years, surgeons and anesthetists have recognized that stress can be present in their daily professional practice. The goal of this study was to identify tools for assessing stress and cognitive load in the operating room.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MATERIAL AND METHODS: We conducted a literature review in the PubMed database of scientific articles published on the subject without date limit using the keywords anesthesia, surgery, surgeon, cognitive workload, definition, pathophysiology, physiological measurement, objective, subjective, stress.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Nineteen articles were selected, focusing on cardiac surgery, gastrointestinal surgery, vascular surgery and urology. No publications concerning ophthalmology were found through the literature search. The means of measurement found were either subjective, such as questionnaires, or objective, such as the study of heart rate variability (HRV), reaction time, eye movements, electrical conductivity of the skin, biological markers and electroencephalogram. Of all these measurement tools, the NASA-TLX questionnaire, used in four articles, and the HRV study, used in eight articles, appear to be the most widely used and are strongly correlated with stress.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: The articles reviewed use only some of the available tools for assessment of stress and cognitive load. The main objective is to improve the quality of care and the quality of life of caregivers. It would be interesting to develop other methods to identify and better characterize the risk factors that increase stress and cognitive load.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37068974/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37068974</a> | DOI:<a href=https://doi.org/10.1016/j.jfo.2022.11.021>10.1016/j.jfo.2022.11.021</a></p></div> Feasibility pilot trial for the Trajectories of Recovery after Intravenous propofol versus inhaled VolatilE anesthesia (THRIVE) pragmatic randomised controlled trial https://pubmed.ncbi.nlm.nih.gov/37068889/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:479412fe-c677-b483-f4b6-168f4d0fd847 Mon, 17 Apr 2023 00:00:00 +0000 INTRODUCTION: Millions of patients receive general anaesthesia for surgery annually. Crucial gaps in evidence exist regarding which technique, propofol total intravenous anaesthesia (TIVA) or inhaled volatile anaesthesia (INVA), yields superior patient experience, safety and outcomes. The aim of this pilot study is to assess the feasibility of conducting a large comparative effectiveness trial assessing patient experiences and outcomes after receiving propofol TIVA or INVA. <div><p style="color: #4aa564;">BMJ Open. 2023 Apr 17;13(4):e070096. doi: 10.1136/bmjopen-2022-070096.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">INTRODUCTION: Millions of patients receive general anaesthesia for surgery annually. Crucial gaps in evidence exist regarding which technique, propofol total intravenous anaesthesia (TIVA) or inhaled volatile anaesthesia (INVA), yields superior patient experience, safety and outcomes. The aim of this pilot study is to assess the feasibility of conducting a large comparative effectiveness trial assessing patient experiences and outcomes after receiving propofol TIVA or INVA.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND ANALYSIS: This protocol was cocreated by a diverse team, including patient partners with personal experience of TIVA or INVA. The design is a 300-patient, two-centre, randomised, feasibility pilot trial. Patients 18 years of age or older, undergoing elective non-cardiac surgery requiring general anaesthesia with a tracheal tube or laryngeal mask airway will be eligible. Patients will be randomised 1:1 to propofol TIVA or INVA, stratified by centre and procedural complexity. The feasibility endpoints include: (1) proportion of patients approached who agree to participate; (2) proportion of patients who receive their assigned randomised treatment; (3) completeness of outcomes data collection and (4) feasibility of data management procedures. Proportions and 95% CIs will be calculated to assess whether prespecified thresholds are met for the feasibility parameters. If the lower bounds of the 95% CI are above the thresholds of 10% for the proportion of patients agreeing to participate among those approached and 80% for compliance with treatment allocation for each randomised treatment group, this will suggest that our planned pragmatic 12 500-patient comparative effectiveness trial can likely be conducted successfully. Other feasibility outcomes and adverse events will be described.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">ETHICS AND DISSEMINATION: This study is approved by the ethics board at Washington University (IRB# 202205053), serving as the single Institutional Review Board for both participating sites. Recruitment began in September 2022. Dissemination plans include presentations at scientific conferences, scientific publications, internet-based educational materials and mass media.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">TRIAL REGISTRATION NUMBER: NCT05346588.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37068889/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37068889</a> | DOI:<a href=https://doi.org/10.1136/bmjopen-2022-070096>10.1136/bmjopen-2022-070096</a></p></div> Can Cardiac Surgery Lead to ICD-11 PTSD and Complex PTSD? Findings of a 5-year Follow-up Study https://pubmed.ncbi.nlm.nih.gov/37067614/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:5f7c0425-a317-4fbc-6162-32745e7f2182 Mon, 17 Apr 2023 00:00:00 +0000 Cardiac surgery may lead to various neuropsychiatric conditions, including posttraumatic stress disorder (PTSD). The 11th revision of the International Classification of Diseases (ICD-11) included a new complex posttraumatic stress disorder (CPTSD) disorder in addition to PTSD. This study aimed to explore whether cardiac surgery could be associated with PTSD and CPTSD at a five-year follow-up after cardiac surgery. The study sample comprised 210 patients (mean age 67, 69.5% male) who had... <div><p style="color: #4aa564;">Psychiatr Q. 2023 Apr 17. doi: 10.1007/s11126-023-10023-0. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cardiac surgery may lead to various neuropsychiatric conditions, including posttraumatic stress disorder (PTSD). The 11th revision of the International Classification of Diseases (ICD-11) included a new complex posttraumatic stress disorder (CPTSD) disorder in addition to PTSD. This study aimed to explore whether cardiac surgery could be associated with PTSD and CPTSD at a five-year follow-up after cardiac surgery. The study sample comprised 210 patients (mean age 67, 69.5% male) who had undergone cardiac surgery. The self-report International Trauma Questionnaire (ITQ) was used to assess ICD-11 PTSD and CPTSD. The Medical Outcomes Study 36 Item Short Form Health Survey (SF-36) questionnaire was used to measure health-related quality of life (HRQOL). We found 5.2% of cardiac surgery-related probable PTSD and CPTSD at a 5-year follow-up, 1.9% PTSD, and 3.3% CPTSD. Low HRQOL was associated with a high risk for PTSD/CPTSD at follow-up. The results showed that cardiac surgery might have a long-term effect on PTSD and CPTSD symptoms. Patients with low HRQOL are at higher risk of having PTSD/CPTSD risk. The study informs about the need for psychosocial interventions to reduce the impact of cardiac surgery on neuropsychiatric conditions and the improvement of HRQOL.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37067614/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37067614</a> | DOI:<a href=https://doi.org/10.1007/s11126-023-10023-0>10.1007/s11126-023-10023-0</a></p></div> Anatomic Considerations after Commando Double Valve Reconstruction: Insights for Future Valve-in -Valve Therapies https://pubmed.ncbi.nlm.nih.gov/37067485/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:cd49fc67-5069-9c71-3ebe-25aed74958f4 Mon, 17 Apr 2023 00:00:00 +0000 CONCLUSIONS: Aortomitral curtain length, as determined by location of aortic valve annular sutures, may be an important consideration in surgical decision-making for valve-in-valve after the Commando procedure. <div><p style="color: #4aa564;">Eur J Cardiothorac Surg. 2023 Apr 17:ezad155. doi: 10.1093/ejcts/ezad155. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: The Commando technique for reconstruction of the aortomitral intervalvular fibrous body is effective to facilitate double valve surgery in cases of endocarditis or infiltrative calcification. The length of patch utilized in reconstruction of the intervalvular fibrous body has an important relationship to the geometry of the mitral and aortic valves and may impact on potential future valve-in-valve therapy. Here we report anatomic measurements after Commando reconstruction in a small group of patients and analyze the impact of reconstruction techniques on transcatheter valve-in-valve therapies.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Seven patients from January 2018 to April 2022 who underwent double valve surgery with the Commando technique with postoperative computed tomography scans were identified. Computed tomographic reconstruction of the aortic and mitral valves was performed using 3mensio software and virtual transcatheter valve replacement was performed. Two of these patients who had preoperative imaging was analyzed to assess the change in aortomitral geometry resulting from reconstruction.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Measurements for each patient post-reconstruction are given in Table 1. Aortomitral length was grossly inversely proportional to aortomitral angle. Aortomitral angle and aortomitral curtain length were significantly altered post-Commando in two analyzed patients with pre- and post-operative computed tomography scan. Transcatheter aortic and mitral valve replacements were feasible in all patients post-Commando. The aortomitral angle was larger and more favorable for mitral valve-in-valve in patients in which the aortomitral curtain was short.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Aortomitral curtain length, as determined by location of aortic valve annular sutures, may be an important consideration in surgical decision-making for valve-in-valve after the Commando procedure.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37067485/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37067485</a> | DOI:<a href=https://doi.org/10.1093/ejcts/ezad155>10.1093/ejcts/ezad155</a></p></div> A patient with heart failure, who is frail: How does this affect therapeutic decisions? https://pubmed.ncbi.nlm.nih.gov/37067336/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:6b2a4f7d-e28e-4c5f-4a65-dd2875509c46 Mon, 17 Apr 2023 00:00:00 +0000 Patients with heart failure (HF) are heterogeneous, not only related to comorbidities but also in the presentation of frailty syndrome. Frailty syndrome also affects patients with HF across the lifespan. Frailty in patients with HF has a significant impact on clinical features, diagnosis, management, adverse medical outcomes and costs. In everyday clinical practice, frail patients with HF require an individualized approach, often imposing the need to modify therapeutic decisions. The aim of this... <div><p style="color: #4aa564;">Cardiol J. 2023 Apr 17. doi: 10.5603/CJ.a2023.0027. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Patients with heart failure (HF) are heterogeneous, not only related to comorbidities but also in the presentation of frailty syndrome. Frailty syndrome also affects patients with HF across the lifespan. Frailty in patients with HF has a significant impact on clinical features, diagnosis, management, adverse medical outcomes and costs. In everyday clinical practice, frail patients with HF require an individualized approach, often imposing the need to modify therapeutic decisions. The aim of this review is to illustrate how frailty and multimorbidity in HF can affect therapeutic decisions. The scientific evidence underlying this publication was obtained from an analysis of papers indexed in the PubMed database. The search was limited to articles published between 1990 and July 2022. The search was limited to full-text papers published in English. The database was searched for relevant MeSH phrases and their combinations and keywords including: "elderly, frail"; "frailty, elderly"; "frail older adults"; "frailty, older adults"; "adult, frail older"; "frailty, heart failure"; "frailty, multimorbidity"; "multimorbidity, heart failure"; "multimorbidity, elderly"; "older adults, cardiovascular diseases". In therapeutic decisions regarding patients with HF, additionally burdened with multimorbidity and frailty, it becomes necessary to individualize the approach in relation to optimization and treatment of coexisting diseases, frailty assessment, pharmacological and non-pharmacological treatment and in the implementation of invasive procedures in the form of implantable devices or cardiac surgery.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37067336/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37067336</a> | DOI:<a href=https://doi.org/10.5603/CJ.a2023.0027>10.5603/CJ.a2023.0027</a></p></div> Robotic redo totally endoscopic coronary artery bypass to the right coronary artery in a patient with prior coronary bypass surgery https://pubmed.ncbi.nlm.nih.gov/37067055/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:4cf95305-e548-d436-6417-446b754e8b1a Mon, 17 Apr 2023 00:00:00 +0000 Surgical revascularization of the right coronary artery in a patient with previous coronary bypass surgery is rare and challenging. One alternative to the resternotomy approach, the subxiphoid approach with the right gastroepiploic artery, has been safely utilized to prevent injury to prior patent grafts. However, this approach might not be suitable for a patient who has adhesions that are the result of a prior abdominal operation. We describe in this case report a technique for robotic totally... <div><p style="color: #4aa564;">Multimed Man Cardiothorac Surg. 2023 Apr 17;2023. doi: 10.1510/mmcts.2023.012.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Surgical revascularization of the right coronary artery in a patient with previous coronary bypass surgery is rare and challenging. One alternative to the resternotomy approach, the subxiphoid approach with the right gastroepiploic artery, has been safely utilized to prevent injury to prior patent grafts. However, this approach might not be suitable for a patient who has adhesions that are the result of a prior abdominal operation. We describe in this case report a technique for robotic totally endoscopic right internal thoracic artery bypass to the right coronary artery in a patient with a previous coronary artery bypass operation and abdominal surgery.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37067055/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37067055</a> | DOI:<a href=https://doi.org/10.1510/mmcts.2023.012>10.1510/mmcts.2023.012</a></p></div> Survival after PCI or CABG for left main stem coronary stenosis. A single institution registry from the NOBLE study period https://pubmed.ncbi.nlm.nih.gov/37066675/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:ad039c95-3839-c5ed-6d33-38db6f1219d4 Mon, 17 Apr 2023 00:00:00 +0000 Objective. To analyze 10 years mortality in an all-comers registry of patients with left main coronary artery stenoses treated with either PCI or CABG. Design. Patients with left main coronary stenoses treated with either PCI or CABG in the period of the NOBLE trial (2010-2015) were all included in an institutional database and registry (University Hospital North Norway). Fifty-six of totally 429 patients were included in the randomized, multicenter and international NOBLE trail; 426 eligible... <div><p style="color: #4aa564;">Scand Cardiovasc J. 2023 Dec;57(1):2197184. doi: 10.1080/14017431.2023.2197184.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"><i>Objective.</i> To analyze 10 years mortality in an all-comers registry of patients with left main coronary artery stenoses treated with either PCI or CABG. <i>Design.</i> Patients with left main coronary stenoses treated with either PCI or CABG in the period of the NOBLE trial (2010-2015) were all included in an institutional database and registry (University Hospital North Norway). Fifty-six of totally 429 patients were included in the randomized, multicenter and international NOBLE trail; 426 eligible patients from the trial and registry were analyzed for mortality on 20 October 2020. The longest observation time on this date was 3611 days (9.9 years); 205 patients were treated with PCI and 221 with CABG. The patients treated with PCI were 74 ± 10 years vs 68 ± 10 years (CABG). Also, on average the PCI patients had more comorbidities (lower ejection fraction, more peripheral artery disease, more often acute presentation). <i>Results</i>. Survival at the last observation date was 80% for CABG patients vs 48% for PCI. A Cox proportional hazards analysis found PCI to be the strongest independent predictor for mortality (HR = 2.5, 95% CI 1.7-3.7). Also, COPD, chronic kidney disease, age, peripheral vascular disease, cerebrovascular incidents and acute presentation were factor predicting increased 10 years mortality. <i>Conclusion</i>. These data indicate that life expectancy in the overall patient population is shorter for patient treated for left main disease with PCI than with CABG.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37066675/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37066675</a> | DOI:<a href=https://doi.org/10.1080/14017431.2023.2197184>10.1080/14017431.2023.2197184</a></p></div> A signature of pre-operative biomarkers of cellular senescence to predict risk of cardiac and kidney adverse events after cardiac surgery https://pubmed.ncbi.nlm.nih.gov/37066343/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:7e06f78c-50d7-de36-e20f-1ba088540c41 Mon, 17 Apr 2023 00:00:00 +0000 CONCLUSIONS: A six-member network of biomarkers of senescence, a fundamental mechanism of aging, can identify patients for risk of adverse kidney and cardiac events when measured pre-operatively. <div><p style="color: #4aa564;">medRxiv. 2023 Apr 11:2023.04.03.23288081. doi: 10.1101/2023.04.03.23288081. Preprint.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: Understand the potential for pre-operative biomarkers of cellular senescence, a primary aging mechanism, to predict risk of cardiac surgery-associated adverse events.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Biomarkers of senescence were assessed in blood samples collected prior to surgery in 331 patients undergoing CABG +/-valve repair or replacement. Patients were followed throughout the hospital stay and at a 30-day follow-up visit. Logistic regression models for pre-operative risk prediction were built for age-related clinical outcomes with high incidence including KDIGO-defined acute kidney injury (AKI), decline in eGFR ≥25% between pre-op and 30 days, and MACKE30, a composite endpoint of major adverse cardiac and kidney events at 30d.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: AKI occurred in 19.9% of patients, persistent decline in kidney function at 30d occurred in 11.0%, and MACKE30 occurred in 13.4%. A network of six biomarkers of senescence (p16, p14, LAG3, CD244, CD28 and suPAR) were able to identify patients at risk for AKI (AUC 0.76), kidney decline at 30d (AUC 0.73), and MACKE30 (AUC 0.71). Comparing the top and bottom tertiles of senescence-based risk models, patients in the top tertile had 7.8 (3.3-8.4) higher odds of developing AKI, 4.5 (1.6-12.6) higher odds of developing renal decline at 30d, and 5.7 (2.1-15.6) higher odds of developing MACKE30. All models remained significant when adjusted for clinical variables. Patients with kidney function decline at 30d were largely non-overlapping and clinically distinct from those who experienced AKI, suggesting a different etiology. Typical clinical factors that predispose to AKI (e.g., age, CKD, surgery type) associated with AKI but not the 30d decline endpoint which was instead associated with new-onset atrial fibrillation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: A six-member network of biomarkers of senescence, a fundamental mechanism of aging, can identify patients for risk of adverse kidney and cardiac events when measured pre-operatively.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37066343/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37066343</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10104239/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">PMC10104239</a> | DOI:<a href=https://doi.org/10.1101/2023.04.03.23288081>10.1101/2023.04.03.23288081</a></p></div> Atrial Fusocellular Sarcoma: An Uncommon Presentation https://pubmed.ncbi.nlm.nih.gov/37065836/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:8ac317fc-2f14-aa53-f354-6f63f0368374 Mon, 17 Apr 2023 00:00:00 +0000 No abstract <div><p style="color: #4aa564;">CASE (Phila). 2023 Jan 21;7(3):105-108. doi: 10.1016/j.case.2022.11.007. eCollection 2023 Mar.</p><p><b>ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37065836/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37065836</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10103005/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">PMC10103005</a> | DOI:<a href=https://doi.org/10.1016/j.case.2022.11.007>10.1016/j.case.2022.11.007</a></p></div> Evaluation of the contribution of gut microbiome dysbiosis to cardiac surgery-associated acute kidney injury by comparative metagenome analysis https://pubmed.ncbi.nlm.nih.gov/37065117/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:1729c124-d353-cbc6-8854-40df8980b752 Mon, 17 Apr 2023 00:00:00 +0000 CONCLUSION: Dysbiosis of the intestinal microbiota in preoperative stool affects susceptibility to CSA-AKI, indicating the crucial role of key microbial players in the development of CSA-AKI. This work provides valuable knowledge for further study of the contribution of gut microbiota in CSA-AKI. <div><p style="color: #4aa564;">Front Microbiol. 2023 Mar 17;14:1119959. doi: 10.3389/fmicb.2023.1119959. eCollection 2023.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">INTRODUCTION: Cardiac surgery-associated acute kidney injury (CSA-AKI) is a common hospital-acquired AKI that carries a grave disease burden. Recently, gut-kidney crosstalk has greatly changed our understanding of the pathogenesis of kidney diseases. However, the relationship between gut microbial dysbiosis and CSA-AKI remains unclear. The purpose of this study was to investigate the possible contributions of gut microbiota alterations in CSA-AKI patients.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Patients undergoing cardiac surgery were enrolled and divided into acute kidney injury (AKI) and Non_AKI groups. Faecal samples were collected before the operation. Shotgun metagenomic sequencing was performed to identify the taxonomic composition of the intestinal microbiome. All groups were statistically compared with alpha- and beta-diversity analysis, and linear discriminant analysis effect size (LEfSe) analysis was performed.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 70 individuals comprising 35 AKI and 35 Non_AKI were enrolled in the study. There was no significant difference between the AKI and Non_AKI groups with respect to the alpha-and beta-diversity of the Shannon index, Simpson or Chao1 index values except with respect to functional pathways (<i>p</i> &lt; 0.05). However, the relative abundance of top 10 gut microbiota in CSA-AKI was different from the Non_AKI group. Interestingly, both LEfSe and multivariate analysis confirmed that the species <i>Escherichia coli</i>, <i>Rothia mucilaginosa</i>, and <i>Clostridium innocuum</i> were associated with CSA-AKI. Moreover, correlation heat map indicated that altered pathways and disrupted function could be attributed to disturbances of gut microbiota involving <i>Escherichia coli</i>.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Dysbiosis of the intestinal microbiota in preoperative stool affects susceptibility to CSA-AKI, indicating the crucial role of key microbial players in the development of CSA-AKI. This work provides valuable knowledge for further study of the contribution of gut microbiota in CSA-AKI.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37065117/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37065117</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10091463/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">PMC10091463</a> | DOI:<a href=https://doi.org/10.3389/fmicb.2023.1119959>10.3389/fmicb.2023.1119959</a></p></div> Tradition or Innovation in Sternal Dehiscence Repair: Robicsek Versus Titanium Plate https://pubmed.ncbi.nlm.nih.gov/37064859/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:c137820e-ea68-6a9e-09ef-eb4acd15c299 Mon, 17 Apr 2023 00:00:00 +0000 CONCLUSION: As supported by most studies in the literature, titanium plate application provides a superior sternum stabilization compared to the classical wire cerclage method. When evaluated in terms of cost-effectiveness, titanium plate method can be applied in high-risk patients in terms of sternal dehiscence. <div><p style="color: #4aa564;">Sisli Etfal Hastan Tip Bul. 2023 Mar 21;57(1):124-129. doi: 10.14744/SEMB.2022.73454. eCollection 2023.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: Sternotomy is still the most commonly used incision in cardiac surgery. Sternal complications are seen at a rate of 0.5% to 6.1%. Sternal dehiscence increases morbidity and mortality after cardiac surgery. To prevent dehiscence, the search for alternative sternum closure methods continues today. Titanium plates produced for this purpose can also be used in patients who are re-operated due to sternal dehiscence. In our study, we investigated the effects of titanium plate repair and robicsek repair on the results in patients who were reoperated due to sternal dehiscence.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Thirty-four patients who underwent reoperation due to sternal detachment in our hospital between September 2013 and December 2020 and had no signs of infection in the pre-operative period were analyzed retrospectively. The patients were divided into three groups according to the surgical method applied. These groups are as follows: Group 1: The cases in which the robicsek method was used, Group 2: the cases in which the titanium plate method was used, and Group 3: The cases where the robicsek + titanium plate methods were used together.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: There was no significant difference between the groups in terms of basic demographic characteristics and risk factors, leading to sternal dehiscence. There was no significant difference between the groups in terms of mortality and length of hospital stay. Considering the infection rates in the post-operative period, 20% and 21.4% post-operative infections were detected in Group 1 and Group 3, respectively, while 70% post-operative infection was observed in Group 2, which was repaired only with the Robicsek technique (p&lt;0.05).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: As supported by most studies in the literature, titanium plate application provides a superior sternum stabilization compared to the classical wire cerclage method. When evaluated in terms of cost-effectiveness, titanium plate method can be applied in high-risk patients in terms of sternal dehiscence.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37064859/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37064859</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10098402/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">PMC10098402</a> | DOI:<a href=https://doi.org/10.14744/SEMB.2022.73454>10.14744/SEMB.2022.73454</a></p></div> Self-Expanding Versus Balloon Expanding Coronary Stents in Intervention of the Degenerated Saphenous Vein Graft: Memmingen Coronary Artery Bypass Stenosis Trial (MECAST) https://pubmed.ncbi.nlm.nih.gov/37064643/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:cb0022f6-c13b-4b0e-87b9-1dcb161dfd97 Mon, 17 Apr 2023 00:00:00 +0000 CONCLUSION: Our findings demonstrate that SVG treatment with SExS is safe and provides clinical benefits by comparatively improving short and especially long-term patient outcomes. <div><p style="color: #4aa564;">J Interv Cardiol. 2023 Apr 6;2023:9412132. doi: 10.1155/2023/9412132. eCollection 2023.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: The aim of this retrospective analysis was to compare the patient outcome after interventional therapy of saphenous vein graft (SVG) stenoses in an all-comers population receiving either self-expanding drug-eluting stents (SExS) or balloon expanding drug-eluting stents (BExS).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: The interventional therapy of degenerated SVGs remains challenging. Diameter variations of stenotic segments and friable plaques can lead to malapposition and distal embolization with increased major adverse cardiac event (MACE) rates.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: 107 patients with a total of 130 SVG interventions were separated into two groups according to either SExS (<i>n</i> = 51) or BExS (<i>n</i> = 56) treatment. Primary endpoint was the MACE rate, which is defined as the composite of cardiac death, myocardial infarction (MI), target vessel (TVR), and target lesion revascularization (TLR) at 30 days and at one-year follow-up.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Both patient groups did not differ significantly regarding patient characteristics. The patient outcome was significantly better in the SExS patient group: the MACE rate at 30 days was 1/51 (2.0%) in group SExS vs. 7/56 (12.5%) in group BExS; <i>p</i> &lt; 0.05. At one-year follow-up, the MACE rate remained significantly lower in the SExS group 8/51(15.7%) vs. 20/56 (35.7%) in the BExS group, <i>p</i> &lt; 0.02. Additionally, cardiac death occurred significantly later within the SExS patient group compared to the BExS group (<i>p</i> &lt; 0.05). A better overall outcome of patients with de novo SVG-stenosis compared to patients with previous CABG (coronary artery bypass graft) intervention was noted in both groups.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Our findings demonstrate that SVG treatment with SExS is safe and provides clinical benefits by comparatively improving short and especially long-term patient outcomes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37064643/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37064643</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10101740/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">PMC10101740</a> | DOI:<a href=https://doi.org/10.1155/2023/9412132>10.1155/2023/9412132</a></p></div> Case report: Treatment of left-sided valve endocarditis using the Transapical AngioVac System and cerebral embolism protection device: A case series https://pubmed.ncbi.nlm.nih.gov/37063967/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:60e42b43-66bf-29e4-a7c8-d82f2667438f Mon, 17 Apr 2023 00:00:00 +0000 The AngioVac System (AngioDynamics, Latham, NY) was developed for the treatment of right-sided heart and intravenous masses. Lately, it has been employed to deal with left-sided heart masses, in particular, native valve endocarditis (NVE) and valve prostheses endocarditis (VPE) in high-risk patients. Left-sided heart endocarditis has a high morbidity, and it also has a high mortality when open heart surgery is performed. Recently, patients presenting with left NVE and VPE have been treated with... <div><p style="color: #4aa564;">Front Cardiovasc Med. 2023 Mar 30;10:1121488. doi: 10.3389/fcvm.2023.1121488. eCollection 2023.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The AngioVac System (AngioDynamics, Latham, NY) was developed for the treatment of right-sided heart and intravenous masses. Lately, it has been employed to deal with left-sided heart masses, in particular, native valve endocarditis (NVE) and valve prostheses endocarditis (VPE) in high-risk patients. Left-sided heart endocarditis has a high morbidity, and it also has a high mortality when open heart surgery is performed. Recently, patients presenting with left NVE and VPE have been treated with the off-label use of the AngioVac System even if the solution presents a considerable cerebral embolization risk issue due to the risk of fragmentation rather than a complete en-bloc aspiration of the masses. A percutaneous cerebral embolism protection system is currently used in TAVI procedures, especially when the native valve presents extensive calcifications and consequent significant embolic risks. We hereby present a clinical case series of a combined utilization of the AngioVac System and cerebral embolism protection system Triguard (Keystone Heart Ltd., Herzliya, Israel) to treat left NVE and VPE in prohibitive-surgical-risk patients.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37063967/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37063967</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10097912/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">PMC10097912</a> | DOI:<a href=https://doi.org/10.3389/fcvm.2023.1121488>10.3389/fcvm.2023.1121488</a></p></div> Corrigendum: The effect of topical airway anesthesia on hemodynamic profile during the induction period in patients undergoing cardiac surgery: Study protocol for a randomized controlled trial https://pubmed.ncbi.nlm.nih.gov/37063952/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:a24ed4a7-e1c8-4b4b-455a-c6095b391d05 Mon, 17 Apr 2023 00:00:00 +0000 [This corrects the article DOI: 10.3389/fcvm.2022.992534.]. <div><p style="color: #4aa564;">Front Cardiovasc Med. 2023 Mar 31;10:1190323. doi: 10.3389/fcvm.2023.1190323. eCollection 2023.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">[This corrects the article DOI: 10.3389/fcvm.2022.992534.].</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37063952/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37063952</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10104600/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">PMC10104600</a> | DOI:<a href=https://doi.org/10.3389/fcvm.2023.1190323>10.3389/fcvm.2023.1190323</a></p></div> Preoperative inflammatory markers predict postoperative clinical outcomes in patients undergoing heart valve surgery: A large-sample retrospective study https://pubmed.ncbi.nlm.nih.gov/37063874/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:4db5ad00-67cf-4549-6a3f-8aaa4ec42221 Mon, 17 Apr 2023 00:00:00 +0000 CONCLUSION: Preoperative inflammation can affect postoperative outcomes in patients undergoing heart valve surgery. CRP level >5 mg/L and NLR >3.5 can effectively predict postoperative heart failure and death within 30 days after surgery, respectively. <div><p style="color: #4aa564;">Front Immunol. 2023 Mar 31;14:1159089. doi: 10.3389/fimmu.2023.1159089. eCollection 2023.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">INTRODUCTION: Preoperative inflammation affects the postoperative outcomes of patients undergoing heart valve surgery. This study aimed to explore the role and predictive effects of preoperative inflammation on the primary outcomes after valvular cardiac surgery.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: This retrospective study utilized a medical recording system to screen 5075 patients who underwent heart valve surgery. Data on the C-reactive protein (CRP) levels, erythrocyte sedimentation rate (ESR), and neutrophil-to-lymphocyte ratio (NLR) before heart valve surgery were collected from the hospital's medical system. Postoperative hepatic insufficiency, acute kidney injury, heart failure, and myocardial damage were assessed using blood indicators. Patients with and without prolonged mechanical ventilation, extended intensive care unit stays, prolonged hospital stays, and death within 30 days after surgery (considered the primary outcome in this study) were compared. Group comparisons, receiver operating characteristic (ROC) curve analyses, and logistic analyses were performed to determine the associations between preoperative inflammation and outcomes after heart valve surgery.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 3249 patients were included in the analysis. Significant differences in CRP level, ESR, and NLR were found between patients with and without postoperative adverse outcomes. ROC analysis showed that CRP levels &gt;5 mg/L effectively predicted postoperative heart failure, and NLR &gt;3.5 had a good predictive effect on all-cause mortality within 30 days after surgery. Patients with CRP levels &gt;5 mg/L had a higher incidence of postoperative heart failure than other patients (20.7% vs. 12.6%, <i>P</i>&lt;0.001), with a relative risk of 1.447 (95% confidence interval: 1.155-1.814). Patients with NLR &gt;3.5 had a higher incidence of death within 30 days after surgery (5.3% vs. 1.2%, <i>P</i>&lt;0.001), with a relative risk of 3.236 (95% confidence interval: 1.773-5.906).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Preoperative inflammation can affect postoperative outcomes in patients undergoing heart valve surgery. CRP level &gt;5 mg/L and NLR &gt;3.5 can effectively predict postoperative heart failure and death within 30 days after surgery, respectively.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37063874/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37063874</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10102463/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">PMC10102463</a> | DOI:<a href=https://doi.org/10.3389/fimmu.2023.1159089>10.3389/fimmu.2023.1159089</a></p></div> Cardiac surgery in acute heparin-induced thrombocytopenia managed with therapeutic plasma exchange and intravenous immunoglobulin https://pubmed.ncbi.nlm.nih.gov/37063753/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:21b01c0b-5f52-7fa6-5405-2475dffc10ca Mon, 17 Apr 2023 00:00:00 +0000 CONCLUSION: Dissociation between antigen-based (enzyme-linked immunosorbent assay) and functional (serotonin release assay) testing was noted, and TPE coupled to IVIg was associated with an excellent clinical response. <div><p style="color: #4aa564;">Res Pract Thromb Haemost. 2023 Feb 23;7(2):100089. doi: 10.1016/j.rpth.2023.100089. eCollection 2023 Feb.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Urgent surgery requiring heparin exposure during cardiopulmonary bypass can be challenging in patients with acute heparin-induced thrombocytopenia (HIT). The use of treatments such as therapeutic plasma exchange (TPE) to remove HIT antibodies and intravenous immunoglobulin (IVIg) to antagonize HIT antibody-mediated platelet activation are increasingly reported in patients who undergo cardiac surgery. The optimal treatment approach to mitigate the risks of heparin administration in this situation is not known.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">KEY CLINICAL QUESTION: Can TPE coupled to IVIg allow for safe heparin exposure in patients with HIT?</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CLINICAL APPROACH: TPE and IVIg were used to enable heparin exposure for surgical placement of a left ventricular assist device in a patient with HIT. Serial patient samples were tested in antigen-based and functional HIT assays.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Dissociation between antigen-based (enzyme-linked immunosorbent assay) and functional (serotonin release assay) testing was noted, and TPE coupled to IVIg was associated with an excellent clinical response.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37063753/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37063753</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10099300/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">PMC10099300</a> | DOI:<a href=https://doi.org/10.1016/j.rpth.2023.100089>10.1016/j.rpth.2023.100089</a></p></div> Correlation between perioperative dexmedetomidine administration and postoperative acute kidney injury in hypertensive patients undergoing non-cardiac surgery https://pubmed.ncbi.nlm.nih.gov/37063282/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:0f116aff-59c7-6979-d396-8f11a5cd3168 Mon, 17 Apr 2023 00:00:00 +0000 Background: Previous studies have suggested that dexmedetomidine may have a protective effect on renal function. However, it is currently unclear whether perioperative dexmedetomidine administration is associated with postoperative acute kidney injury (AKI) incidence risk in hypertensive patients undergoing non-cardiac surgery. Methods: This investigation was a retrospective cohort study. Hypertensive patients undergoing non-cardiac surgery in Third Xiangya Hospital of Central South University... <div><p style="color: #4aa564;">Front Pharmacol. 2023 Mar 29;14:1143176. doi: 10.3389/fphar.2023.1143176. eCollection 2023.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"><b>Background:</b> Previous studies have suggested that dexmedetomidine may have a protective effect on renal function. However, it is currently unclear whether perioperative dexmedetomidine administration is associated with postoperative acute kidney injury (AKI) incidence risk in hypertensive patients undergoing non-cardiac surgery. <b>Methods:</b> This investigation was a retrospective cohort study. Hypertensive patients undergoing non-cardiac surgery in Third Xiangya Hospital of Central South University from June 2018 to December 2019 were included. The relevant data were extracted through electronic cases. The univariable analysis identified demographic, preoperative laboratory, and intraoperative factors associated with acute kidney injury. Multivariable stepwise logistic regression was used to assess the association between perioperative dexmedetomidine administration and postoperative acute kidney injury after adjusting for interference factors. In addition, we further performed sensitivity analyses in four subgroups to further validate the robustness of the results. <b>Results:</b> A total of 5769 patients were included in this study, with a 7.66% incidence of postoperative acute kidney injury. The incidence of postoperative acute kidney injury was lower in the dexmedetomidine-administered group than in the control group (4.12% vs. 8.06%, <i>p</i> &lt; 0.001). In the multivariable stepwise logistic regression analysis, perioperative dexmedetomidine administration significantly reduced the risk of postoperative acute kidney injury after adjusting for interference factors [odds ratio (OR) = 0.56, 95% confidence interval (CI): 0.36-0.87, <i>p</i> = 0.010]. In addition, sensitivity analysis in four subgroups indicated parallel findings: i) eGRF &lt;90 mL/min·1.73/m<sup>2</sup> subgroup (OR = 0.40, 95% CI: 0.19-0.84, <i>p</i> = 0.016), ii) intraoperative blood loss &lt;1000 mL subgroup (OR = 0.58, 95% CI: 0.36-0.94, <i>p</i> = 0.025), iii) non-diabetes subgroup (OR = 0.51, 95% CI: 0.29-0.89, <i>p</i> = 0.018), and iv) older subgroup (OR = 0.55, 95% CI: 0.32-0.93, <i>p</i> = 0.027). <b>Conclusion:</b> In conclusion, our study suggests that perioperative dexmedetomidine administration is associated with lower risk and less severity of postoperative acute kidney injury in hypertensive individuals undergoing non-cardiac surgery. Therefore, future large-scale RCT studies are necessary to validate this benefit.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37063282/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37063282</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10090366/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">PMC10090366</a> | DOI:<a href=https://doi.org/10.3389/fphar.2023.1143176>10.3389/fphar.2023.1143176</a></p></div> Multiple arterial versus single arterial grafting in patients with diabetes undergoing coronary artery bypass surgery https://pubmed.ncbi.nlm.nih.gov/37063161/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:c7b8757a-4115-371b-4666-55bb860c8cee Mon, 17 Apr 2023 00:00:00 +0000 CONCLUSIONS: Patients with diabetes benefit from receiving MAG over SAG and demonstrated improved long-term survival, and lower hazards of secondary and composite outcomes. Coordinated efforts are needed to offer MAG to patients with diabetes. <div><p style="color: #4aa564;">JTCVS Open. 2023 Jan 28;13:119-135. doi: 10.1016/j.xjon.2023.01.010. eCollection 2023 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Data on long-term outcomes in patients with diabetes receiving multiarterial grafting (MAG) versus single-artery grafting (SAG) are limited.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: The objective of this study is to compare long-term outcomes between MAG and SAG for coronary artery bypass graft (CABG) surgery in patients with diabetes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Patients with diabetes who underwent isolated CABG surgeries between 2000 to 2016 were identified using the New Jersey mandatory state clinical registry linked with death records and hospital discharge data (last follow-up December 31, 2019). Patients who underwent CABG for single-vessel disease, with only venous conduits, patients with previous heart surgeries, or hemodynamically unstable were excluded. Patients undergoing MAG and SAG were matched by propensity score. Cox proportional hazard models were used to investigate long-term survival and competing risk analysis was used for secondary outcomes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Of 24,944 patients, 2955 underwent MAG, and 21,989 underwent SAG CABG. Patients receiving MAG were younger, predominantly men, with a lower prevalence of hypertension, peripheral vascular disease, congestive heart failure, chronic lung disease, and renal failure. MAG was associated with lower long-term mortality compared with SAG in 2882 propensity score-matched pairs (hazard ratio [HR], 0.75; 95% CI, 0.68-0.83); lower risks of repeat revascularization (subdistribution HR, 0.86; 95% CI, 0.76-0.97); and composite outcome defined as death from any cause, stroke, postoperative myocardial infarction, and/or repeat revascularization (HR, 0.76; 95% CI, 0.71-0.82). These results were confirmed in subgroup analyses of women, men, age &lt;70 years, and age ≥70 years patients with diabetes. MAG was also associated with lower mortality compared with SAG in patients with diabetes taking insulin in the entire cohort (Video Abstract).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Patients with diabetes benefit from receiving MAG over SAG and demonstrated improved long-term survival, and lower hazards of secondary and composite outcomes. Coordinated efforts are needed to offer MAG to patients with diabetes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37063161/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37063161</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10091389/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">PMC10091389</a> | DOI:<a href=https://doi.org/10.1016/j.xjon.2023.01.010>10.1016/j.xjon.2023.01.010</a></p></div> Left atrial appendage closure during cardiac surgery: Safe but underutilized in California https://pubmed.ncbi.nlm.nih.gov/37063156/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:a981c869-4b41-75d7-7c03-4db831eb33e4 Mon, 17 Apr 2023 00:00:00 +0000 CONCLUSIONS: LAA closure was associated with minimal surgical morbidity, and reduced short- and midterm incidence of stroke/systemic embolism. Although the use of LAA closure has increased, substantial variation exists among programs in California, suggesting the need for further standardization of care. <div><p style="color: #4aa564;">JTCVS Open. 2022 Dec 9;13:150-162. doi: 10.1016/j.xjon.2022.11.016. eCollection 2023 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: Left atrial appendage (LAA) closure is associated with reduced rates of stroke in patients with atrial fibrillation (AF). We evaluated trends in LAA closure, the association of LAA closure with stroke/systemic embolism, and its safety profile in patients with AF who underwent cardiac surgery in California. We further tested for hospital-level variation in concomitant LAA closure.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Adults who underwent coronary artery bypass grafting and/or valve surgery with preoperative AF were identified in the 2016 to 2019 Office of Statewide Health Planning and Development databases. Propensity score matching was performed to study risk-adjusted associations of LAA closure with ischemic stroke/systemic embolism. Hospital-level variation was studied using intraclass correlation coefficients.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Among 18,434 patients with AF who underwent coronary artery bypass grafting/valve surgery, 47.7% received LAA closure. Rates of LAA closure increased from 44.4% to 51.4% from 2016 to 2019 (<i>P</i> &lt; .001). In 4652 propensity score-matched patients, LAA closure was associated with reduced incidence of stroke/systemic embolism at discharge (1.6% vs 3.1%; <i>P</i> &lt; .001) and readmission with stroke/systemic embolism at 1 year (2.9% vs 4.5%; <i>P</i> = .004). LAA closure was not associated with acute kidney injury, pulmonary complications, blood transfusion, reoperation, or in-hospital mortality. Approximately 18% of the risk-adjusted variation in LAA use was attributed to the hospital, with median center-level rate of 44.9% (interquartile range, 29.6%-57.4%).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: LAA closure was associated with minimal surgical morbidity, and reduced short- and midterm incidence of stroke/systemic embolism. Although the use of LAA closure has increased, substantial variation exists among programs in California, suggesting the need for further standardization of care.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37063156/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37063156</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10091286/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">PMC10091286</a> | DOI:<a href=https://doi.org/10.1016/j.xjon.2022.11.016>10.1016/j.xjon.2022.11.016</a></p></div> Analysis of risk factors associated with extracorporeal membrane oxygenation after surgical repair of peripheral pulmonary artery stenoses https://pubmed.ncbi.nlm.nih.gov/37063146/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:0d860735-ff48-5813-6e63-77acc85349e8 Mon, 17 Apr 2023 00:00:00 +0000 CONCLUSIONS: The data demonstrate multiple differences between patients who did and did not require extracorporeal membrane oxygenation after surgical repair of peripheral pulmonary artery stenosis. These results suggest that the preoperative extent of disease may predispose to the development of acute lung injury requiring extracorporeal membrane oxygenation support. <div><p style="color: #4aa564;">JTCVS Open. 2023 Jan 31;13:344-356. doi: 10.1016/j.xjon.2023.01.011. eCollection 2023 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: Acute lung injury is a known complication of pulmonary artery reconstruction for peripheral pulmonary artery stenosis. Severe cases may require support with extracorporeal membrane oxygenation. The purpose of this study was to evaluate the characteristics of patients requiring extracorporeal membrane oxygenation after pulmonary artery reconstruction.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: This was a retrospective study of 150 patients who underwent surgical repair of peripheral pulmonary artery stenosis at our institution from 2002 to 2022. Underlying diagnoses included Williams syndrome (n = 44), Alagille syndrome (n = 43), elastin arteriopathy (n = 21), tetralogy of Fallot (n = 21), and other (n = 21). Characteristics of patients who required extracorporeal membrane oxygenation were compared with those who did not require extracorporeal membrane oxygenation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Eleven of the 150 patients undergoing pulmonary artery reconstruction (7.3%) required postoperative extracorporeal membrane oxygenation support (10 for acute lung injury and 1 for cardiac insufficiency). Four patients receiving extracorporeal membrane oxygenation had Williams syndrome, 3 patients had Alagille, and 4 patients had tetralogy of Fallot. Patients requiring extracorporeal membrane oxygenation had a higher preoperative right ventricle to aortic peak systolic pressure ratios (mean 1.14 vs 0.95), greater number of pulmonary artery ostial interventions (median, 23 vs 17), and longer duration of cardiopulmonary bypass (median, 597 vs 400 minutes). There were 3 in-hospital deaths (2.0%), 2 of whom required postoperative extracorporeal membrane oxygenation support.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: The data demonstrate multiple differences between patients who did and did not require extracorporeal membrane oxygenation after surgical repair of peripheral pulmonary artery stenosis. These results suggest that the preoperative extent of disease may predispose to the development of acute lung injury requiring extracorporeal membrane oxygenation support.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37063146/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37063146</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10091391/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">PMC10091391</a> | DOI:<a href=https://doi.org/10.1016/j.xjon.2023.01.011>10.1016/j.xjon.2023.01.011</a></p></div> Design of the Randomized Controlled Trial Comparing Dimethyl Sulfoxide Cryopreserved Platelets to Liquid Stored Platelets in Patients Undergoing Cardiopulmonary Bypass Surgery https://pubmed.ncbi.nlm.nih.gov/37063119/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:c1bdb907-8075-bdef-f553-f0cb0d6ddec7 Mon, 17 Apr 2023 00:00:00 +0000 CONCLUSIONS: Frozen storage could substantially safely extend the shelf life of stored platelets. If efficacy and safety were demonstrated in this trial, current constraints on platelet use in low resource military and civilian settings would be relieved. <div><p style="color: #4aa564;">JTCVS Open. 2022 Nov 12;13:232-241. doi: 10.1016/j.xjon.2022.11.003. eCollection 2023 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: Dimethylsulfoxide-cryopreserved platelets are being evaluated for treatment of acute hemorrhage in patients with thrombocytopenia or platelet dysfunction when liquid stored platelets are unavailable. Patients undergoing cardiac surgery with cardiopulmonary bypass with risk factors for significant bleeding represent a population for which determining efficacy and safety of cryopreserved platelets is ideal in the clinical trial setting. The primary objective is to compare blood loss in cardiopulmonary bypass patients receiving cryopreserved platelets or liquid stored platelets.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: In patients undergoing cardiac surgery utilizing cardiopulmonary bypass, a standardized algorithm with transfusion triggers will be used to guide the intra- and postoperative administration of study platelets, either cryopreserved platelets or liquid stored platelets, based on the clinical presentation. The primary efficacy end point was the volume of blood loss from completion of chest closure (time 0) until the time chest tubes were removed or 24 hours after chest closure, whichever is earlier.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: This design article describes an ongoing multicenter, randomized, blinded trial to evaluate noninferiority or superiority of cryopreserved platelets with liquid stored platelets in controlling blood loss in patients undergoing cardiopulmonary bypass surgery.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Frozen storage could substantially safely extend the shelf life of stored platelets. If efficacy and safety were demonstrated in this trial, current constraints on platelet use in low resource military and civilian settings would be relieved.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37063119/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37063119</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10091215/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">PMC10091215</a> | DOI:<a href=https://doi.org/10.1016/j.xjon.2022.11.003>10.1016/j.xjon.2022.11.003</a></p></div> Association of ectatic non-infarct-related artery with 1-month stent thrombosis in patients with ST elevation myocardial infarction https://pubmed.ncbi.nlm.nih.gov/37062981/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:34d1ddc3-9d81-9721-0667-37f19619a679 Mon, 17 Apr 2023 00:00:00 +0000 CONCLUSION: Ectatic non-IRA presence without ectatic IRA in patients with STEMI increases the risk of ST within the first month of pPCI. <div><p style="color: #4aa564;">Postgrad Med J. 2022 Sep 1;98(1163):660-665. doi: 10.1136/postgradmedj-2021-141483.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Ectatic infarct-related artery (IRA) has been shown to be associated with higher thrombus burden, no-reflow, stent thrombosis (ST) and major adverse cardiovascular events in patients with ST-elevation myocardial infarction (STEMI). The effect of ectatic non-IRA on ST without ectatic IRA is not known. We aimed to assess the effect of ectatic non-IRA presence on ST within 1 month after primary percutaneous intervention (pPCI) in patients with STEMI.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A total of 1541 patients with a diagnosis of STEMI and underwent pPCI between 2015 and 2020 were retrospectively included in the study. Patients with and without 1 month ST were compared. Penalised logistic regression method was used to assess the association between ST and candidate predictors due to the risk of overfitting.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Median age of the study group was 56.5 (48.7 to 67.2) years. The Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) score, ectatic non-IRA presence and use of tirofiban were significantly higher in the ST group (18.2±9.9 vs 15.1±9.9, p=0.03; 25% vs 7.2%, p&lt;0.001; 54.2% vs 30.5%, p&lt;0.001; respectively). Significantly higher thrombus aspiration (14.3% vs 6.7%, p=0.03) and lower stent implantation (67.7% vs 84%, p&lt;0.001) rates were observed in ectatic IRA group compared with ectatic non-IRA group. In multivariable analysis, ectatic non-IRA presence was independently associated with 1-month ST (OR 4.01, 95% CI 1.86 to 8.63, p=0.01).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Ectatic non-IRA presence without ectatic IRA in patients with STEMI increases the risk of ST within the first month of pPCI.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37062981/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37062981</a> | DOI:<a href=https://doi.org/10.1136/postgradmedj-2021-141483>10.1136/postgradmedj-2021-141483</a></p></div> Increasing obesity is associated with lower postoperative bleeding in coronary bypass patients https://pubmed.ncbi.nlm.nih.gov/37062665/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:f8be15c8-c99d-e284-f90b-7c372d90ca1c Sun, 16 Apr 2023 00:00:00 +0000 CONCLUSION: Patients with high BMI may carry protection against postoperative bleeding after cardiac surgery, probably secondary to an inherent hypercoagulable state, whereas underweight patients carry a higher risk of bleeding and worse outcomes. <div><p style="color: #4aa564;">J Cardiothorac Vasc Anesth. 2023 Mar 17:S1053-0770(23)00181-7. doi: 10.1053/j.jvca.2023.03.012. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: Despite inherent comorbidities, obese cardiac surgical patients paradoxically had shown lower morbidity and mortality, although the nature of this association is still unclear. Thus, the authors intended in this large registry-based study to investigate the impact of obesity on short- and long-term postoperative outcomes, focusing on bleeding and transfusion requirements.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN: Retrospective registry study.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">SETTING: Three university hospitals.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">PARTICIPANTS: A cohort of 12,330 prospectively compiled data from coronary bypass grafting patients undergoing surgery between 2007 to 2020 were retrieved from the Western Denmark Heart Registry.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">INTERVENTIONS: The parameters were analyzed to assess the association between body mass index (BMI) and the selected outcome parameters.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MEASUREMENTS AND MAIN RESULTS: The crude data showed a clear statistically significant association in postoperative drainage from 637 (418-1108) mL in underweight patients with BMI &lt;18.5 kg/m<sup>2</sup> to 427 (295-620) mL in severely obese patients with BMI ≥40 kg/m<sup>2</sup> (p &lt; 0.0001, Kruskal-Wallis). Further, 50.0% of patients with BMI &lt;18.5 received an average of 451 mL/m<sup>2</sup> in red blood cell transfusions, compared to 16.7% of patients with BMI &gt;40 receiving 84 mL/m<sup>2</sup>. The obese groups were less often submitted to reexploration due to bleeding, and fewer received perioperative hemostatics, inotropes, and vasoconstrictors. The crude data showed increasing 30-day and 6-month mortality with lower BMI, whereas the one-year mortality showed a V-shaped pattern, but BMI had no independent impact on mortality in logistic regression analysis.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Patients with high BMI may carry protection against postoperative bleeding after cardiac surgery, probably secondary to an inherent hypercoagulable state, whereas underweight patients carry a higher risk of bleeding and worse outcomes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37062665/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37062665</a> | DOI:<a href=https://doi.org/10.1053/j.jvca.2023.03.012>10.1053/j.jvca.2023.03.012</a></p></div> Structural and Electrical Integrity of Transesophageal Echocardiography Probes: Importance and Key Concepts https://pubmed.ncbi.nlm.nih.gov/37062664/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:c601725a-6ff7-8372-a870-16e927e9fbef Sun, 16 Apr 2023 00:00:00 +0000 The clinical utility of transesophageal echocardiography (TEE) is well-established for patients undergoing cardiac surgery. With the increase in percutaneous structural heart disease procedures that rely on TEE for procedural guidance, the use of TEE probes is expanding. Although there are well-established protocols for routine cleaning and decontaminating TEE probes between patient use, there is a lack of awareness and misconceptions about maintaining TEE probes' structural and electrical... <div><p style="color: #4aa564;">J Cardiothorac Vasc Anesth. 2023 Mar 16:S1053-0770(23)00184-2. doi: 10.1053/j.jvca.2023.03.015. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The clinical utility of transesophageal echocardiography (TEE) is well-established for patients undergoing cardiac surgery. With the increase in percutaneous structural heart disease procedures that rely on TEE for procedural guidance, the use of TEE probes is expanding. Although there are well-established protocols for routine cleaning and decontaminating TEE probes between patient use, there is a lack of awareness and misconceptions about maintaining TEE probes' structural and electrical integrity. The electrical leakage test (ELT) is routinely performed between patient use. From a patient safety standpoint, the ELT is necessary to ensure the longevity of this expensive equipment and prevent disruptions to the workflow in a busy department caused by TEE probes being decommissioned due to probe damage. This technical communication aims to highlight the importance of maintaining TEE probes' structural and electrical integrity. The article also highlights and discusses probe handling techniques between patient use, emphasizing the ELT to ensure patient safety and compliance with national and international standards.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37062664/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37062664</a> | DOI:<a href=https://doi.org/10.1053/j.jvca.2023.03.015>10.1053/j.jvca.2023.03.015</a></p></div> What's fishy about protamine? Clinical use, adverse reactions, and potential alternatives https://pubmed.ncbi.nlm.nih.gov/37062523/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:aaf4d014-995f-b4a1-8b23-801de0ca1267 Sun, 16 Apr 2023 00:00:00 +0000 Protamine, a highly basic protein isolated from salmon sperm, is the only clinically available agent to reverse the anticoagulation of unfractionated heparin. Following intravenous administration, protamine binds to heparin in a nonspecific electrostatic interaction to reverse its anticoagulant effects. In clinical use, protamine is routinely administered to reverse high-dose heparin anticoagulation in cardiovascular procedures, including cardiac surgery with cardiopulmonary bypass. Despite the... <div><p style="color: #4aa564;">J Thromb Haemost. 2023 Apr 14:S1538-7836(23)00319-7. doi: 10.1016/j.jtha.2023.04.005. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Protamine, a highly basic protein isolated from salmon sperm, is the only clinically available agent to reverse the anticoagulation of unfractionated heparin. Following intravenous administration, protamine binds to heparin in a nonspecific electrostatic interaction to reverse its anticoagulant effects. In clinical use, protamine is routinely administered to reverse high-dose heparin anticoagulation in cardiovascular procedures, including cardiac surgery with cardiopulmonary bypass. Despite the lack of supportive evidence regarding protamine's effectiveness to reverse low molecular weight heparin, it is recommended in guidelines with low-quality evidence. Different dosing strategies have been reported for reversing heparin in cardiac surgical patients based on empiric dosing, pharmacokinetics, or point of care measurements of heparin levels. Protamine administration is associated with a spectrum of adverse reactions that range from vasodilation to life-threatening cardiopulmonary dysfunction and shock. The life-threatening responses appear to be hypersensitivity reactions due to IgE and/or IgG antibodies. However, protamine and heparin-protamine complexes can activate complement, inflammatory pathways, and inhibit other coagulation factors. Although alternative agents for reversing heparin are not currently available for clinical use, additional research continues evaluating novel therapeutic approaches.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37062523/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37062523</a> | DOI:<a href=https://doi.org/10.1016/j.jtha.2023.04.005>10.1016/j.jtha.2023.04.005</a></p></div> Quality of Life and Pain Syndrome in Patients With Thoracic Aorta Repair Using a Mini-Sternotomy https://pubmed.ncbi.nlm.nih.gov/37061860/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:57f58a1c-bd98-2ce4-52b5-dd6871b4c7fb Sun, 16 Apr 2023 00:00:00 +0000 Aim To determine the effect of minimally invasive interventions on the quality of life (QoL), pain syndrome, and cosmetic effect in patients with a pathology of chest aorta as compared with a group of traditional access.Material and methods From 2016 through 2020, 77 of 226 (34%) patients with an aneurysm in the proximal chest aorta and mini-sternotomy were prospectively selected starting from 2017. To evaluate differences between the effects of mini-sternotomy and the traditional access on QoL... <div><p style="color: #4aa564;">Kardiologiia. 2023 Mar 31;63(3):46-54. doi: 10.18087/cardio.2023.3.n1957.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Aim To determine the effect of minimally invasive interventions on the quality of life (QoL), pain syndrome, and cosmetic effect in patients with a pathology of chest aorta as compared with a group of traditional access.Material and methods From 2016 through 2020, 77 of 226 (34%) patients with an aneurysm in the proximal chest aorta and mini-sternotomy were prospectively selected starting from 2017. To evaluate differences between the effects of mini-sternotomy and the traditional access on QoL and pain syndrome a control group of patients with full sternotomy (n=77) was formed using pseudorandomization. Intergroup comparison of QoL, pain syndrome, and cosmetic parameters was performed at various time points.Results Mini-sternotomy provided a decrease in pain syndrome both during the early period (day 3), and during movements upon discharge. Also, mini-sternotomy decreased the duration of stay in the hospital compared to full sternotomy (8.1±2.1 vs. 8.9±2.5 days, respectively; р&amp;gt;0.0331). A more frequent use of analgesics by patients with full sternotomy was noted. Mini-sternotomy was associated with a faster recovery of most QoL parameters according to the SF-36 questionnaire at one year after surgery. The questionnaire included summarizing parameters of physical and mental health components (Physical Health Component, Physical Health (PH): 54.3±11.9 vs. 58.2±8.2, respectively; p=0.046; Mental Health Component, Mental Health (MH): 53.8±6.8 vs. 57.8±9.5, respectively; p=0.013). In addition, patients with minimal access showed higher values of the cosmetic effect by a 5-score scale (4.08±0.8 vs. 4.39±0.8, respectively; p=0.049) and a greater interest to having a minimal access surgery.Conclusion Mini-sternotomy beneficially influences the pain syndrome, cosmetic outcome, and QoL and provides a shorter duration of rehabilitation and a sooner return to work and everyday life compared to full sternotomy.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37061860/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37061860</a> | DOI:<a href=https://doi.org/10.18087/cardio.2023.3.n1957>10.18087/cardio.2023.3.n1957</a></p></div> Effect of preoperative risk on the association between intraoperative hypotension and postoperative acute kidney injury in cardiac surgery https://pubmed.ncbi.nlm.nih.gov/37061091/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:4d4aba63-0f1c-ad0f-8a2e-3e220fca4898 Sat, 15 Apr 2023 00:00:00 +0000 CONCLUSION: IOH is a significant independent risk factor for AKI after cardiac surgery. Patients with higher baseline risk showed a more prominent relationship between IOH and postoperative AKI than low-risk patients. <div><p style="color: #4aa564;">Anaesth Crit Care Pain Med. 2023 Apr 13:101233. doi: 10.1016/j.accpm.2023.101233. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Acute kidney injury (AKI), a common and severe complication after cardiac surgery, has been demonstrated to be associated with intraoperative hypotension (IOH). The reproducibility of this finding and whether preoperative risk modifies the association remain unclear. We hypothesised that the relationship between IOH and AKI after cardiac surgery varies by preoperative risk.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We conducted a single-centre, retrospective cohort study to analyse the association between IOH and postoperative AKI by stratifying patients using preoperative risk factors. IOH was defined as a mean arterial pressure (MAP) of less than 65 mm Hg and characterised by the cumulative duration and area under the curve (AUC).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Ten variables could be identified as risk factors: age, smoking status, NYHA III/Ⅳ, emergent surgery, peripheral vascular disease, cerebrovascular disease, heart failure, hypertension, previous cardiac surgery, and NT-proBNP concentration. The risk prediction model divided the patients into three equal-sized preoperative risk stratifications. Low-risk patients demonstrated no associations between AKI and IOH of any severity, while high-risk patients demonstrated a statistically significant association between AKI and milder IOH with a cumulative duration greater than 104 min (adjusted odds ratio [OR]: 2.27, 95% confidence interval [CI]: 1.10-4.74; and adjusted OR: 3.63, 95% CI: 1.77-7.58) and an AUC greater than 905 mm Hg min (adjusted OR: 2.08, 95% CI: 1.01-4.36; and adjusted OR: 4.00, 95% CI: 1.95-8.43).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: IOH is a significant independent risk factor for AKI after cardiac surgery. Patients with higher baseline risk showed a more prominent relationship between IOH and postoperative AKI than low-risk patients.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37061091/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37061091</a> | DOI:<a href=https://doi.org/10.1016/j.accpm.2023.101233>10.1016/j.accpm.2023.101233</a></p></div> Risk factors for development of acute kidney injury and acute kidney disease in critically ill children https://pubmed.ncbi.nlm.nih.gov/37060439/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:8b620c24-337a-2cca-56f5-9b76eddac6ab Sat, 15 Apr 2023 00:00:00 +0000 CONCLUSION: AKI and AKD were common among critically ill children, and are associated with significant morbidity and mortality. Few modifiable risk factors, especially those related to nephrotoxic medication exposure, were associated with AKI development and AKD progression. <div><p style="color: #4aa564;">J Nephrol. 2023 Apr 15. doi: 10.1007/s40620-023-01613-z. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Acute kidney injury (AKI) is common among critically ill children and these children are at risk of developing acute kidney disease (AKD).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A prospective cohort study was conducted on children aged &gt; 1 month to ≤ 18 years old admitted to the pediatric intensive care unit (ICU) of Hong Kong Children's Hospital from 6/2020 to 6/2021. The incidences and risk factors of both AKI and AKD were determined.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: There were 254 eligible admissions (58.3% in males, with a mean age of 6.4 ± 5.5 years). The overall AKI incidence was 41.7% and 56% of children who remained hospitalized in the pediatric ICU for ≥ 7 days after acquiring AKI developed AKD. Cardiac surgery, bone marrow transplantation and requirement of inotropes were risk factors for both AKI and AKD. The requirement of non-invasive ventilation [relative risk (RR): 2.625 (1.361, 5.064)], total medication dose [RR 1.006 (1.002, 1.010)] and maximal medication intensity [RR 1.154 (1.038, 1.283)] were additional determinants of AKI. Factors indicating more severe AKI and AKI progression were predictive of AKD development. The overall mortality in the pediatric ICU was 3.1%. AKI was significantly associated with mortality (p &lt; 0.001), longer length of hospitalization in the pediatric ICU (p &lt; 0.001) and hospital stay (p &lt; 0.001). AKD was associated with a lower estimated glomerular filtration rate at discharge from the pediatric ICU (p = 0.036).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: AKI and AKD were common among critically ill children, and are associated with significant morbidity and mortality. Few modifiable risk factors, especially those related to nephrotoxic medication exposure, were associated with AKI development and AKD progression.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37060439/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37060439</a> | DOI:<a href=https://doi.org/10.1007/s40620-023-01613-z>10.1007/s40620-023-01613-z</a></p></div> Sodium citrate effectively used in shed mediastinal blood autotransfusion after cardiac surgery https://pubmed.ncbi.nlm.nih.gov/37060259/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:9ea384fc-994e-ebb4-ff5b-1095b3a8e3cf Sat, 15 Apr 2023 00:00:00 +0000 CONCLUSIONS: Sodium citrate, as an alternative anticoagulant agent, can be used in autologous shed mediastinal blood transfusion after CPB cardiac surgery. This procedure can effectively reduce the amount of allogeneic blood for patients with haemorrhage. <div><p style="color: #4aa564;">Perfusion. 2023 Apr 15:2676591231171271. doi: 10.1177/02676591231171271. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: We used sodium citrate as an alternative anticoagulation agent to heparin in the procedure of autologous blood transfusion with patients with postoperative haemorrhage after CPB. The aim of study was to evaluate the efficacy and safety of sodium citrate used in shed mediastinal blood autotransfusion after cardiac surgery.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Ninety-three patients were divided into two groups in this study. In the control group, 52 patients' shed mediastinal blood was discarded. The reinfusion group consisted of 41 patients receiving a reinfusion of washed autologous red cells from shed mediastinal blood. Each 400 mL shed blood sample was anticoagulated by 140 mL of 1.6% diluted sodium citrate in the washing procedure using a blood recovery machine. Hemoglobin (Hb), hematocrit (Hct), and electrolyte concentrations in both the patients and shed mediastinal blood were measured before and after this procedure.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The mean volume of autotransfused shed blood was 239.5 ± 54.6 mL.The Hct of the washed red cells was 56.8 ± 6.1%. Significantly, fewer units of allogeneic blood were required per patient in the reinfusion group at 24 h postoperatively (2.91 ± 1.34 vs 4.03 ± 0.19 U, <i>p</i> = 0.002). At 24 h postoperatively, Hb and Hct levels were higher in the reinfusion group than in the control group. The calcium ion concentration was very low in the shed mediastinal blood, 0.25 ± 0.08 mmol/L, and was lower after washing, 0.15 ± 0.04 mmol/L.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Sodium citrate, as an alternative anticoagulant agent, can be used in autologous shed mediastinal blood transfusion after CPB cardiac surgery. This procedure can effectively reduce the amount of allogeneic blood for patients with haemorrhage.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37060259/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37060259</a> | DOI:<a href=https://doi.org/10.1177/02676591231171271>10.1177/02676591231171271</a></p></div> High-flow nasal oxygen vs. standard oxygen therapy for patients undergoing transcatheter aortic valve replacement with conscious sedation: a randomised controlled trial https://pubmed.ncbi.nlm.nih.gov/37060038/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:d5c3f927-4ae3-45cc-8e7c-b8ef8591c30e Fri, 14 Apr 2023 00:00:00 +0000 CONCLUSION: This study has demonstrated that high flow, compared with standard oxygen therapy, does not improve arterial oxygenation over the course of the procedure. There are suggestions that it may improve the secondary outcomes studied. <div><p style="color: #4aa564;">Perioper Med (Lond). 2023 Apr 14;12(1):11. doi: 10.1186/s13741-023-00300-8.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Minimally invasive surgery is becoming more common and transfemoral transcatheter aortic valve replacement is offered to older patients with multiple comorbidities. Sternotomy is not required but patients must lie flat and still for up to 2-3 h. This procedure is increasingly being performed under conscious sedation with supplementary oxygen, but hypoxia and agitation are commonly observed.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: In this randomised controlled trial, we hypothesised that high-flow nasal oxygen would provide superior oxygenation as compared with our standard practice, 2 l min<sup>-1</sup> oxygen by dry nasal specs. This was administered using the Optiflow THRIVE Nasal High Flow delivery system (Fisher and Paykel, Auckland, New Zealand) at a flow rate of 50 l min<sup>-1</sup> and FiO<sub>2</sub> 0.3. The primary endpoint was the change in arterial partial pressure of oxygen (pO<sub>2</sub>) during the procedure. Secondary outcomes included the incidence of oxygen desaturation, airway interventions, the number of times the patient reached for the oxygen delivery device, incidence of cerebral desaturation, peri-operative oxygen therapy duration, hospital length of stay and patient satisfaction scores.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 72 patients were recruited. There was no difference in change in pO<sub>2</sub> from baseline using high-flow compared with standard oxygen therapy: median [IQR] increase from 12.10 (10.05-15.22 [7.2-29.8]) to 13.69 (10.85-18.38 [8.5-32.3]) kPa vs. decrease from 15.45 (12.17-19.33 [9.2-22.8]) to 14.20 (11.80-19.40 [9.7-35.1]) kPa, respectively. The percentage change in pO2 after 30 min was also not significantly different between the two groups (p = 0.171). There was a lower incidence of oxygen desaturation in the high-flow group (p = 0.027). Patients in the high-flow group assigned a significantly higher comfort score to their treatment (p ≤ 0.001).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: This study has demonstrated that high flow, compared with standard oxygen therapy, does not improve arterial oxygenation over the course of the procedure. There are suggestions that it may improve the secondary outcomes studied.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">TRIAL REGISTRATION: International Standard Randomised Controlled Trial Number (ISRCTN) 13,804,861. Registered on 15 April 2019. https://doi.org/10.1186/ISRCTN13804861.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37060038/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37060038</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10103409/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">PMC10103409</a> | DOI:<a href=https://doi.org/10.1186/s13741-023-00300-8>10.1186/s13741-023-00300-8</a></p></div> Anatomical and biometric study of the mitral valve apparatus: application in valve repair surgery https://pubmed.ncbi.nlm.nih.gov/37060017/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:7b30d190-dcd3-2fbe-ef6d-15382f172f72 Fri, 14 Apr 2023 00:00:00 +0000 CONCLUSION: A perfect knowledge of anatomy and biometry is therefore essential to offer alternative techniques that reproduce the real anatomy and physiology with a complete reconstruction of the mitral valve. <div><p style="color: #4aa564;">J Cardiothorac Surg. 2023 Apr 14;18(1):141. doi: 10.1186/s13019-023-02232-2.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: Most mitral valve repair techniques provide excellent surgical results by removing regurgitation, but all of these techniques simultaneously reduce posterior valve mobility. A comprehensive biometric study of the mitral valve apparatus will provide landmarks that would help improve this posterior valve mobility.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MATERIALS AND METHODS: Thirty one (31) human hearts have been studied, from 14 women and 17 men. The characteristics of the studied sample were analyzed descriptively. The difference in means of the variables between women and men were tested using a Student t test. Correlations between the different measures were determined by simple regression analysis. Mean values are shown with ± 1 standard deviation and the limit of significance was set at 0.05.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The mean weight of the hearts was 275.3 ± 2.4 g. The anteroposterior diameter of the mitral annulus was 29.3 ± 1.22 mm, the intertrigonal distance was 25.2 ± 3.50 mm and the anterior leaflet to posterior leaflet ratio was 1.9 ± 0.10, the length of the chordae A2 = 19.4 ± 1.15 mm and P2 = 14.5 ± 0.85 mm. The length of the anterior papillary muscle averaged 30.9 ± 7.20 mm and that of the posterior one 30.0 ± 8.75 mm. The comparison of the different values measured between women and men showed no statistically significant difference (p &gt; 0.05). There was no correlation between these different measured values (p &gt; 0.05).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: A perfect knowledge of anatomy and biometry is therefore essential to offer alternative techniques that reproduce the real anatomy and physiology with a complete reconstruction of the mitral valve.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37060017/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37060017</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10105398/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">PMC10105398</a> | DOI:<a href=https://doi.org/10.1186/s13019-023-02232-2>10.1186/s13019-023-02232-2</a></p></div> Fluid-structure interaction modelling of a positive-displacement Total Artificial Heart https://pubmed.ncbi.nlm.nih.gov/37059748/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:a1264b72-cd5b-7249-2bff-9c6a7facf1ca Fri, 14 Apr 2023 00:00:00 +0000 For those suffering from end-stage biventricular heart failure, and where a heart transplantation is not a viable option, a Total Artificial Heart (TAH) can be used as a bridge to transplant device. The Realheart TAH is a four-chamber artificial heart that uses a positive-displacement pumping technique mimicking the native heart to produce pulsatile flow governed by a pair of bileaflet mechanical heart valves. The aim of this work was to create a method for simulating haemodynamics in... <div><p style="color: #4aa564;">Sci Rep. 2023 Apr 14;13(1):5734. doi: 10.1038/s41598-023-32141-2.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">For those suffering from end-stage biventricular heart failure, and where a heart transplantation is not a viable option, a Total Artificial Heart (TAH) can be used as a bridge to transplant device. The Realheart TAH is a four-chamber artificial heart that uses a positive-displacement pumping technique mimicking the native heart to produce pulsatile flow governed by a pair of bileaflet mechanical heart valves. The aim of this work was to create a method for simulating haemodynamics in positive-displacement blood pumps, using computational fluid dynamics with fluid-structure interaction to eliminate the need for pre-existing in vitro valve motion data, and then use it to investigate the performance of the Realheart TAH across a range of operating conditions. The device was simulated in Ansys Fluent for five cycles at pumping rates of 60, 80, 100 and 120 bpm and at stroke lengths of 19, 21, 23 and 25 mm. The moving components of the device were discretised using an overset meshing approach, a novel blended weak-strong coupling algorithm was used between fluid and structural solvers, and a custom variable time stepping scheme was used to maximise computational efficiency and accuracy. A two-element Windkessel model approximated a physiological pressure response at the outlet. The transient outflow volume flow rate and pressure results were compared against in vitro experiments using a hybrid cardiovascular simulator and showed good agreement, with maximum root mean square errors of 15% and 5% for the flow rates and pressures respectively. Ventricular washout was simulated and showed an increase as cardiac output increased, with a maximum value of 89% after four cycles at 120 bpm 25 mm. Shear stress distribution over time was also measured, showing that no more than [Formula: see text]% of the total volume exceeded 150 Pa at a cardiac output of 7 L/min. This study showed this model to be both accurate and robust across a wide range of operating points, and will enable fast and effective future studies to be undertaken on current and future generations of the Realheart TAH.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37059748/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37059748</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10104863/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">PMC10104863</a> | DOI:<a href=https://doi.org/10.1038/s41598-023-32141-2>10.1038/s41598-023-32141-2</a></p></div> Platelet Function is Preserved After Moderate Cardiopulmonary Bypass Times But Transiently Impaired After Protamine https://pubmed.ncbi.nlm.nih.gov/37059638/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:5c757379-bbd2-6877-84b0-31730abd48ae Fri, 14 Apr 2023 00:00:00 +0000 CONCLUSIONS: During cardiac surgery with moderate CPB times, platelet function was not impaired, and no consumption of circulating platelets could be detected. Administration of protamine transiently affected platelet function. <div><p style="color: #4aa564;">J Cardiothorac Vasc Anesth. 2023 Mar 13:S1053-0770(23)00180-5. doi: 10.1053/j.jvca.2023.03.013. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: Previous studies have described impaired platelet function after cardiopulmonary bypass (CPB). Whether this is still valid in contemporary cardiac surgery is unclear. This study aimed to quantify changes in function and number of platelets during CPB in a present-day cardiac surgery cohort.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN: Prospective, controlled clinical study.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">SETTING: A single-center university hospital.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">PARTICIPANTS: Thirty-nine patients scheduled for coronary artery bypass graft surgery with CPB.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">INTERVENTIONS: Platelet function and numbers were measured at 6 timepoints in 39 patients during and after coronary artery bypass graft surgery; at baseline before anesthesia, at the end of CPB, after protamine administration, at intensive care unit (ICU) arrival, 3 hours after ICU arrival, and on the morning after surgery.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MEASUREMENTS AND MAIN RESULTS: Platelet function was assessed with impedance aggregometry and flow cytometry. Platelet numbers are expressed as actual concentration and as numbers corrected for dilution using hemoglobin as a reference marker. There was no consistent impairment of platelet function during CPB with either impedance aggregometry or flow cytometry. After protamine administration, a decrease in platelet function was seen with impedance aggregometry and for some markers of activation with flow cytometry. Platelet function was restored 3 hours after arrival in the ICU. During CPB (85.0 ± 21 min), the number of circulating platelets corrected for dilution increased from 1.73 ± 0.42 × 10<sup>9</sup>/g to 1.91 ± 0.51 × 10<sup>9</sup>/g (p &lt; 0.001).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: During cardiac surgery with moderate CPB times, platelet function was not impaired, and no consumption of circulating platelets could be detected. Administration of protamine transiently affected platelet function.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37059638/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37059638</a> | DOI:<a href=https://doi.org/10.1053/j.jvca.2023.03.013>10.1053/j.jvca.2023.03.013</a></p></div> Nurturing the Future of Heart Failure: The HFSA Advanced Heart Failure and Transplant Cardiology Task Force https://pubmed.ncbi.nlm.nih.gov/37059514/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:636a15e6-703f-e42a-a71f-857920bd4a8a Fri, 14 Apr 2023 00:00:00 +0000 No abstract <div><p style="color: #4aa564;">J Card Fail. 2023 Apr;29(4):544-545. doi: 10.1016/j.cardfail.2023.03.007.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37059514/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37059514</a> | DOI:<a href=https://doi.org/10.1016/j.cardfail.2023.03.007>10.1016/j.cardfail.2023.03.007</a></p></div> Epidemiology, Management, and Clinical Outcomes of Extrapulmonary Mycobacterium abscessus Complex Infections in Heart Transplant and Ventricular Assist Device Recipients https://pubmed.ncbi.nlm.nih.gov/37059177/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:9d9c26fd-0fb3-dcba-f5bb-98fd0892d828 Fri, 14 Apr 2023 00:00:00 +0000 Nontuberculous mycobacteria (NTM) are emerging pathogens, yet data on the epidemiology and management of extrapulmonary NTM infections in orthotopic heart transplantation (OHT) and ventricular assist device (VAD) recipients are scarce. We retrospectively reviewed records of OHT and VAD recipients who underwent cardiac surgery at our hospital and developed Mycobacterium abscessus complex (MABC) infection from 2013-2016 during a hospital outbreak of MABC linked to heater-cooler units. We analyzed... <div><p style="color: #4aa564;">Am J Transplant. 2023 Apr 12:S1600-6135(23)00406-9. doi: 10.1016/j.ajt.2023.04.009. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Nontuberculous mycobacteria (NTM) are emerging pathogens, yet data on the epidemiology and management of extrapulmonary NTM infections in orthotopic heart transplantation (OHT) and ventricular assist device (VAD) recipients are scarce. We retrospectively reviewed records of OHT and VAD recipients who underwent cardiac surgery at our hospital and developed Mycobacterium abscessus complex (MABC) infection from 2013-2016 during a hospital outbreak of MABC linked to heater-cooler units. We analyzed patient characteristics, medical and surgical management, and long-term outcomes. Ten OHT and 7 VAD patients developed extrapulmonary M. abscessus subspecies abscessus infection. Median time from presumed inoculation during cardiac surgery to first positive culture was 106 days in OHT and 29 days in VAD recipients. The most common sites of positive cultures were blood (n=12), sternum/mediastinum (n=8), and the VAD driveline exit site (n=7). The 14 patients diagnosed while alive received combination antimicrobial therapy for a median of 21 weeks, developed 28 antibiotic-related adverse events, and underwent 27 surgeries. Only 8 (47%) patients survived longer than 12 weeks after diagnosis, including 2 VAD patients who experienced long-term survival after explantation of infected VADs and OHT. Despite aggressive medical and surgical management, OHT and VAD patients with MABC infection experienced substantial morbidity and mortality.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37059177/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37059177</a> | DOI:<a href=https://doi.org/10.1016/j.ajt.2023.04.009>10.1016/j.ajt.2023.04.009</a></p></div> Efficacy of prophylactic high-flow nasal cannula therapy for postoperative pulmonary complications after pediatric cardiac surgery: a prospective single-arm study https://pubmed.ncbi.nlm.nih.gov/37058243/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:9f7b47ab-c1ce-8d63-4d7f-0251a60a3683 Fri, 14 Apr 2023 00:00:00 +0000 CONCLUSIONS: We found the incidence of PPC with prophylactic HFNC after planned extubation after pediatric cardiac surgery. However, the incidence was > 10%; therefore, we could not demonstrate its efficacy in this single-arm study. Further studies are needed to investigate whether the HFNC could be adapted as first-line oxygen therapy after pediatric cardiac surgery. <div><p style="color: #4aa564;">J Anesth. 2023 Apr 14. doi: 10.1007/s00540-023-03187-3. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">PURPOSE: This study investigated the incidence of postoperative pulmonary complications (PPC) when high-flow nasal cannula therapy (HFNC) is used prophylactically after pediatric cardiac surgery, and evaluated its efficacy.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: This was a single-arm prospective interventional study that was conducted in a tertiary teaching hospital with eight beds in the pediatric cardiac ICU after approval by the Ethics Committee. One-hundred children under the age of 48 months who were scheduled for cardiac surgery for congenital heart disease were recruited. HFNC was used for 24 h after extubation at a 2 L/kg/min flow rate. The primary outcome was the incidence of PPC within 48 h after extubation. PPC was defined as atelectasis and acute respiratory failure meeting certain criteria. We considered prophylactic HFNC as effective if the prevalence of PPC was &lt; 10%, based on previous reports of reintubation rates of 6%-9% after pediatric cardiac surgery.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 91 patients were finally included in the analysis. The incidence of PPC within 48 h after extubation was 18.7%, whereas atelectasis was observed in 13.2%, and acute respiratory failure in 8.8%. Reintubation rate within 48 h after extubation was 0%.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: We found the incidence of PPC with prophylactic HFNC after planned extubation after pediatric cardiac surgery. However, the incidence was &gt; 10%; therefore, we could not demonstrate its efficacy in this single-arm study. Further studies are needed to investigate whether the HFNC could be adapted as first-line oxygen therapy after pediatric cardiac surgery.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37058243/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37058243</a> | DOI:<a href=https://doi.org/10.1007/s00540-023-03187-3>10.1007/s00540-023-03187-3</a></p></div> Creating the optimal preoperative nutritional status for neonates undergoing cardiac surgery by implementing a preoperative nutritional support plan https://pubmed.ncbi.nlm.nih.gov/37057648/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:d9a7d573-ce95-03dc-a797-3616d69af74d Fri, 14 Apr 2023 00:00:00 +0000 CONCLUSION: Nutritional support plans after birth for neonates with severe congenital heart disease can effectively improve the nutritional status of patients before surgery and accelerate the speed of postoperative recovery. <div><p style="color: #4aa564;">J Paediatr Child Health. 2023 Apr 14. doi: 10.1111/jpc.16414. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIM: The purpose of this study was to explore the effect of a preoperative nutritional support programme on improving preoperative nutritional status and promoting postoperative recovery in neonates undergoing cardiac surgery.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: The clinical data of neonates undergoing cardiac surgery who received preoperative nutritional support therapy in our hospital from March 2021 to December 2021 were collected, and the clinical data of neonates undergoing cardiac surgery who did not receive preoperative nutritional support therapy in our hospital from February 2020 to February 2021 were selected as the control. The nutritional status and postoperative recovery of the two groups were compared.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 30 neonates who received nutritional support before cardiac surgery were included in this study. A total of 28 neonates who did not receive nutritional support before cardiac surgery were included in the control group. There were no significant differences in general information or the nutritional status at birth between the two groups. The duration of nutritional support in the intervention group was 16.8 ± 7.1 days. Before the operation, the intervention group was significantly better than the control group in terms of body weight, albumin, prealbumin and haemoglobin, which indicated that the nutritional status of the intervention group was better than that of the control group. The intensive care time, ventilator time and hospital stay time in the intervention group were significantly lower than those in the control group.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Nutritional support plans after birth for neonates with severe congenital heart disease can effectively improve the nutritional status of patients before surgery and accelerate the speed of postoperative recovery.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37057648/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37057648</a> | DOI:<a href=https://doi.org/10.1111/jpc.16414>10.1111/jpc.16414</a></p></div> Prognostic value of perioperative change of neutrophil elastase and myeloperoxidase in coronary circulation on perioperative myocardial injury and clinical outcome of patients underwent surgical valve replacement https://pubmed.ncbi.nlm.nih.gov/37057327/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:42e01df3-ec4e-a307-674b-a08564d543cc Fri, 14 Apr 2023 00:00:00 +0000 Objective: To investigate the clinical value of observing perioperative changes of myeloperoxidase (MPO) and neutrophil elastase (NE) in coronary artery circulation in patients underwent valve replacement surgery. Methods: This perspective cohort study was performed in patients who underwent valvular surgery in Nanjing Drum Tower Hospital and Fuwai Hospital from June 2021 to June 2022. Patients were divided into perioperative myocardial injury group and age-, sex- and type of cardiac... <div><p style="color: #4aa564;">Zhonghua Xin Xue Guan Bing Za Zhi. 2023 Apr 24;51(4):400-406. doi: 10.3760/cma.j.cn112148-20220713-00545.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"><b>Objective:</b> To investigate the clinical value of observing perioperative changes of myeloperoxidase (MPO) and neutrophil elastase (NE) in coronary artery circulation in patients underwent valve replacement surgery. <b>Methods:</b> This perspective cohort study was performed in patients who underwent valvular surgery in Nanjing Drum Tower Hospital and Fuwai Hospital from June 2021 to June 2022. Patients were divided into perioperative myocardial injury group and age-, sex- and type of cardiac procedure-matched non-perioperative myocardial injury control group in the ratio of 1∶1. Perioperative myocardial injury was defined as cardiac troponin T (cTnT)&gt;0.8 μg/L on the first postoperative day (POD), and the cTnT level on the second POD increased by more than 10% compared with the cTnT level on the first POD. During the operation, blood samples were collected from the coronary sinus before clamping ascending aorta, and within 5 minutes after de-clamping ascending aorta. Then, the levels of MPO and NE on coronary sinus were continuously measured. The death, severe ventricular arrhythmia, pneumonia, re-intubation, repeat cardiac surgery, extracorporeal membrane oxygenation (ECMO), intra-aortic balloon pump (IABP), continuous renal replacement therapy (CRRT), mechanical ventilation time and the duration of intensive care unit (ICU) were recorded. The levels of MPO and NE and the incidence of clinical outcomes were compared between the myocardial injury group and the control group. The independent risk factors of myocardial injury were analyzed by multivariate logistic regression. <b>Results:</b> A total of 130 patients were enrolled, aged (60.6±7.6) years old, with 59 males (45.4%). There were 65 patients in the myocardial injury group and 65 patients in the control group. During hospitalization, there was no death, ECMO, IABP and CRRT cases in both groups. Compared with the control group, the incidence of severe ventricular arrhythmia (13.8%(9/65) vs. 3.1%(2/65), <i>P</i>=0.03), pneumonia (20.0%(13/65) vs. 3.1%(2/65), <i>P</i>=0.03), re-intubation (6.2%(4/65) vs. 0, <i>P</i>=0.04) was significantly higher in myocardial injury group. The mechanical ventilation time (16.8(10.7, 101.7) h vs. 7.5(4.7, 15.1) h, <i>P</i>&lt;0.01), and the duration of ICU (3.7(2.7, 18.9) vs. 2.7(1.8, 6.9)d, <i>P</i>&lt;0.01) were significantly longer in myocardial injury group compared with the control group. There was no significant difference in the levels of MPO and NE in coronary sinus blood between the two groups before aortic clamping (all <i>P</i>&gt;0.05). However, MPO ((551.3±124.2) μg/L vs. (447.2±135.9) μg/L, <i>P</i>&lt;0.01) and NE ((417.0±83.1)μg/L vs. (341.0±68.3)μg/L, <i>P</i>&lt;0.01) after 5 min aortic de-clamping were significantly higher in myocardial injury group than in the control group. Multivariate logistic regression analysis showed that the levels of NE (<i>OR</i>=1.02, 95%<i>CI</i>: 1.01-1.02, <i>P</i>&lt;0.01), MPO (<i>OR</i>=1.00, 95%<i>CI</i>: 1.00-1.01, <i>P</i>=0.02) and mechanical ventilation time (<i>OR</i>=1.03, 95%<i>CI</i>: 1.01-1.06, <i>P</i>=0.02) were independent risk factors of myocardial injury in patients after surgical valvular replacement. <b>Conclusion:</b> Perioperative myocardial injury is related poor clinical outcomes, perioperative NE and MPO in coronary artery circulation are independent risk factors of perioperative myocardial injury in patients undergoing valve replacement surgery.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37057327/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37057327</a> | DOI:<a href=https://doi.org/10.3760/cma.j.cn112148-20220713-00545>10.3760/cma.j.cn112148-20220713-00545</a></p></div> Predictive value of the proportion of hibernating myocardium in total perfusion defect on reverse remodeling in patients with HFrEF underwent coronary artery bypass graft https://pubmed.ncbi.nlm.nih.gov/37057325/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:e8e60853-df9d-3519-dc18-d023d2bdba64 Fri, 14 Apr 2023 00:00:00 +0000 Objective: To evaluate the predictive value of the proportion of hibernating myocardium (HM) in total perfusion defect (TPD) on reverse left ventricle remodeling (RR) after coronary artery bypass graft (CABG) in patients with heart failure with reduced ejection fraction (HFrEF) by ^(99m)Tc-methoxyisobutylisonitrile (MIBI) single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) combined with ^(18)F-flurodeoxyglucose (FDG) gated myocardial imaging positron emission... <div><p style="color: #4aa564;">Zhonghua Xin Xue Guan Bing Za Zhi. 2023 Apr 24;51(4):384-392. doi: 10.3760/cma.j.cn112148-20221121-00912.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"><b>Objective:</b> To evaluate the predictive value of the proportion of hibernating myocardium (HM) in total perfusion defect (TPD) on reverse left ventricle remodeling (RR) after coronary artery bypass graft (CABG) in patients with heart failure with reduced ejection fraction (HFrEF) by <sup>99m</sup>Tc-methoxyisobutylisonitrile (MIBI) single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) combined with <sup>18</sup>F-flurodeoxyglucose (FDG) gated myocardial imaging positron emission computed tomography (PET). <b>Methods:</b> Inpatients diagnosed with HFrEF at the Cardiac Surgery Center, Anzhen Hospital of Capital Medical University from January 2016 to January 2022 were prospectively recruited. MPI combined with <sup>18</sup>F-FDG gated PET was performed before surgery for viability assessment and the patients received follow-up MPI and <sup>18</sup>F-FDG gated PET at different stages (3-12 months) after surgery. Δ indicated changes (post-pre). Left ventricular end-systolic volume (ESV) reduced at least 10% was defined as RR, patients were divided into reverse remodeling (RR+) group and the non-reverse group (RR-). Binary logistic regression analysis was used to identify predictors of RR. Receiver operating characteristic (ROC) curve analysis was performed and the area under the curve (AUC) was calculated to assess the cut-off value for predicting RR. Additionally, we retrospectively enrolled inpatients with HFrEF at the Cardiac Surgery Center, Anzhen Hospital of Capital Medical University from January 2021 to January 2022 as the validation group, who underwent MPI and <sup>18</sup>F-FDG gated PET before surgery. Echocardiography was performed before CABG and after CABG (3-12 months). In the validation group, the reliability of obtaining the cut-off value for the ROC curve was verified. <b>Results:</b> A total of 28 patients with HFrEF (26 males; age (56.9±8.7) years) were included in the prospective cohort. HM/TPD was significantly higher in the RR+ group than in the RR- group ((51.8%±17.9%) vs<i>.</i> (35.7%±13.9%), <i>P</i>=0.016). Binary logistic regression analysis revealed that HM/TPD was an independent predictor of RR (Odds ratio=1.073, 95% Confidence interval: 1.005-1.145, <i>P</i>=0.035). ROC curve analysis revealed that HM/TPD=38.3% yielded the highest sensitivity, specificity, and accuracy (all 75%) for predicting RR and the AUC was 0.786 (<i>P</i>=0.011). Meanwhile, a total of 100 patients with HFrEF (90 males; age (59.7±9.6) years) were included in the validation group. In the validation group, HM/TPD=38.3% predicted RR in HFrEF patients after CABG with the highest sensitivity, specificity and accuracy (82%, 60% and 73% respectively). Compared with the HFrEF patients in the HM/TPD&lt;38.3% group (<i>n</i>=36), RR and cardiac function improved more significantly in the HM/TPD≥38.3% group (<i>n</i>=64) (all <i>P</i>&lt;0.05). <b>Conclusions:</b> Preoperative HM/TPD ratio is an independent factor for predicting RR in patients with HFrEF after CABG, and HM/TPD≥38.3% can accurately predict RR and the improvement of cardiac function after CABG.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37057325/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37057325</a> | DOI:<a href=https://doi.org/10.3760/cma.j.cn112148-20221121-00912>10.3760/cma.j.cn112148-20221121-00912</a></p></div> Outcome-oriented integrated zero-defect nursing combined with respiratory functional exercise in the perioperative period of patients with heart bypass https://pubmed.ncbi.nlm.nih.gov/37056807/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:5734ab8f-313c-56df-4a43-cd7f541c87ab Fri, 14 Apr 2023 00:00:00 +0000 CONCLUSION: Outcome-oriented zero-defect integrated nursing in combination with respirational function exercise can efficiently promote the postoperative revival of patients undergoing heart bypass operation, improve their cardiopulmonary function, diminish the occurrence of complications, and improve their life quality. <div><p style="color: #4aa564;">Am J Transl Res. 2023 Mar 15;15(3):2055-2064. eCollection 2023.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: This study aimed to explore the perioperative application of outcome-oriented integrated zero-defect nursing combined with respirational function exercise in patients undergoing cardiac bypass grafting.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: In this retrospective study, the clinical data of 90 patients with bypass surgery in the General Ward of Cardiac Surgery, Beijing Anzhen Hospital Capital Medical University were collected. The patients were assigned into groups A (n=30), B (n=30), and C (n=30) according to different nursing methods. Group A received outcome-oriented integrated zero-defect nursing in combination with respiratory functional exercise administration, group B received outcome-oriented integrated zero-defect nursing, and group C received routine nursing. The postoperative recovery was detected. Left ventricular ejection fraction (LVEF), left ventricular end-diastolic diameter (LVDD), left ventricular end-systolic diameter (LVSD), and interventricular septal thickness (IVST) were assessed among the three groups pre- and post-intervention. The forced expiratory volume in one second (FEV1), forced vital capacity (FVC), arterial partial pressure of oxygen (PaO<sub>2</sub>), and arterial partial pressure of carbon dioxide (PaCO<sub>2</sub>), and blood gas indices were measured before operation and three days after extubation. The occurrence of complications was compared. The quality of life among groups pre- and post-administration was evaluated by the Generic Quality of Life Inventory (GQOLI-74).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The length of hospital stay, first exhaust time, first excretion interval, and intestine sound improvement time in groups A and B were markedly decreased compared with those in group C, and these markers in group A were markedly decreased compared with those in group B (all P&lt;0.05). After the intervention, the levels of LVEF, LVDD, LVSD, IVST and FVC in group A were more improved compared with those in groups B and C, and the levels of FEV1, PaO<sub>2</sub> and PaCO<sub>2</sub> were more improved compared to those in group C (all P&lt;0.05). The incidences of hypotension, subcutaneous hyperemia, pericardial tamponade, short-burst ventricular tachycardia, subacute stent thrombosis and pulmonary complications in group A and group B (13.33%, 23.33%) were significantly lower than those in group C (50.00%) (all P&lt;0.05). After the intervention, the results of social function, physical, psychological function, and material lifecycle status in group A and B were significantly enhanced compared with those in group C, and the indicators in group A were appreciably better compared with those in group B (all P&lt;0.05).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Outcome-oriented zero-defect integrated nursing in combination with respirational function exercise can efficiently promote the postoperative revival of patients undergoing heart bypass operation, improve their cardiopulmonary function, diminish the occurrence of complications, and improve their life quality.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37056807/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37056807</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10086877/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">PMC10086877</a></p></div> Puzzle game-based learning: a new approach to promote learning of principles of coronary artery bypass graft surgery https://pubmed.ncbi.nlm.nih.gov/37055824/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:0362d22b-11b4-3bf8-b4ce-9dbfeffcf0ea Thu, 13 Apr 2023 00:00:00 +0000 CONCLUSION: The results of the present study showed that the use of puzzle games in CABG surgery training led to a significant improvement in the knowledge and cognitive performance of surgical technology students regarding the stages of CABG surgery and its sequence, as well as the tools and equipment used in each stage of surgery and the sequence of their preparation. <div><p style="color: #4aa564;">BMC Med Educ. 2023 Apr 13;23(1):241. doi: 10.1186/s12909-023-04156-w.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">INTRODUCTION: Since learning with high educational quality requires an advanced intervention. This study seeks to answer how many puzzles game-based training can improve knowledge and cognitive function of surgical technology students in CABG surgery and its sequence, as well as the tools and equipment used in each stage of surgery and the sequence of their preparation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MATERIALS AND METHODS: This study was carried out as a quasi-experimental single-group pre-test-post-test, during which, after designing a puzzle game including various stages of surgery (from the preparation of the patient for surgical sutures and the necessary equipment to perform each stage), 18 people from third-year surgical technology students who met the inclusion criteria were entered in the study by convenience sampling method and based on the sample size determined using a similar study and they participated in the test of knowledge and cognitive function, that the validity and reliability were measured, before the intervention and 14 days after the intervention (using a puzzle game). Data were analyzed using descriptive and Wilcoxon statistical tests.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: After the withdrawal of 2 people, 15 person (93.80 per cent) of the students were female, the average age of students was 21.87 ± 0.71 years, and 50% (8 people) of them were 22 years old. Also, the average score of the end-of-semester exam of the heart surgery technology course was 15.19 ± 2.30 (the lowest score was 11.25, and the highest score was 18.63), and the score of 43.80% (7 people) of them were in the range of 15.01-17.70, and their average of grade point average was 17.31 ± 1.10 (the lowest grade point average is 15 and the highest grade point average is 19.36) and grade point average 75% (11 people) of students were 16-18. The average scores of knowledge(5.75 ± 1.65 vs. 2.68 ± 0.79) and cognitive performance(6.31 ± 2.57 vs. 2.00 ± 1.09) of students in the post-intervention phase were significantly higher than the pre-intervention phase (P &lt; 0.0001).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: The results of the present study showed that the use of puzzle games in CABG surgery training led to a significant improvement in the knowledge and cognitive performance of surgical technology students regarding the stages of CABG surgery and its sequence, as well as the tools and equipment used in each stage of surgery and the sequence of their preparation.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37055824/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37055824</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10100633/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">PMC10100633</a> | DOI:<a href=https://doi.org/10.1186/s12909-023-04156-w>10.1186/s12909-023-04156-w</a></p></div> Predictive value of urinary cell cycle arrest biomarkers for all cause-acute kidney injury: a meta-analysis https://pubmed.ncbi.nlm.nih.gov/37055509/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&fc=None&ff=20230419061909&v=2.17.9.post6+86293ac pubmed: chirurgie urn:uuid:b915c445-6d06-6dee-00bf-e783cebb5fca Thu, 13 Apr 2023 00:00:00 +0000 The cell cycle arrest markers tissue inhibitor metalloproteinases-2 (TIMP-2) and insulin-like growth factor-binding protein 7 (IGFBP7) have been identified as potential biomarkers of acute kidney injury (AKI) in critically ill adults in intensive care units and cardiac surgery-associated AKI (CSA-AKI). However, the clinical impact on all-cause AKI remains unclear. Here, we report a meta-analysis performed to evaluate the predictive value of this biomarker for all-cause AKI. The PubMed, Cochrane,... <div><p style="color: #4aa564;">Sci Rep. 2023 Apr 13;13(1):6037. doi: 10.1038/s41598-023-33233-9.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The cell cycle arrest markers tissue inhibitor metalloproteinases-2 (TIMP-2) and insulin-like growth factor-binding protein 7 (IGFBP7) have been identified as potential biomarkers of acute kidney injury (AKI) in critically ill adults in intensive care units and cardiac surgery-associated AKI (CSA-AKI). However, the clinical impact on all-cause AKI remains unclear. Here, we report a meta-analysis performed to evaluate the predictive value of this biomarker for all-cause AKI. The PubMed, Cochrane, and EMBASE databases were systematically searched up to April 1, 2022. We used the Quality Assessment Tool for Diagnosis Accuracy Studies (QUADAS-2) to assess the quality. We extracted useful information from these studies and calculated the sensitivity, specificity, and area under the receiver operating characteristic curve (AUROC). Twenty studies with 3625 patients were included in the meta-analysis. The estimated sensitivity of urinary [TIMP-2] × [IGFBP7] in the diagnosis of all-cause AKI was 0.79 (95% CI 0.72, 0.84), and the specificity was 0.70 (95% CI 0.62, 0.76). The value of urine [TIMP-2] × [IGFBP7] in the early diagnosis of AKI was assessed using a random effects model. The pooled positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratio (DOR) were 2.6 (95% CI 2.1, 3.3), 0.31 (95% CI 0.23, 0.40), and 8 (95% CI 6, 13), respectively. The AUROC was 0.81 (95% CI 0.78-0.84). No significant publication bias was observed in eligible studies. Subgroup analysis indicated that the diagnostic value was related to the severity of AKI, time measurement, and clinical setting. This study shows that urinary [TIMP-2] × [IGFBP7] is a reliable effective predictive test for all cause-AKI. However, whether and how urinary [TIMP-2] × [IGFBP7] can be used in clinical diagnosis still requires further research and clinical trials.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37055509/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">37055509</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10102152/?utm_source=Firefox&utm_medium=rss&utm_content=1b9VCa6FcviTo_DE4aJkoti4XhNlSCJRTXC7FrfBrjEctTXMxV&ff=20230419061909&v=2.17.9.post6+86293ac">PMC10102152</a> | DOI:<a href=https://doi.org/10.1038/s41598-023-33233-9>10.1038/s41598-023-33233-9</a></p></div>